Worldwide burden of cancer attributable to HPV by site, country and HPV type

HPV is the cause of almost all cervical cancer and is responsible for a substantial fraction of other anogenital cancers and oropharyngeal cancers. Understanding the HPV‐attributable cancer burden can boost programs of HPV vaccination and HPV‐based cervical screening. Attributable fractions (AFs) an...

Full description

Saved in:

Bibliographic Details
Published in	International journal of cancer Vol. 141; no. 4; pp. 664 - 670
Main Authors	de Martel, Catherine, Plummer, Martyn, Vignat, Jerome, Franceschi, Silvia
Format	Journal Article
Language	English
Published	United States Wiley Subscription Services, Inc 15.08.2017 John Wiley and Sons Inc
Subjects	Africa South of the Sahara - epidemiology Age Anogenital Anus Anus Neoplasms - virology attributable fraction Australia - epidemiology Cancer Cancer Epidemiology Cervical cancer Cross-protection Developing countries Female Head & neck cancer Human papillomavirus Human papillomavirus 16 - isolation & purification Human papillomavirus 18 - isolation & purification Humans Immunization India - epidemiology Infections LDCs Male Medical research Medical screening Neck New Zealand - epidemiology Oropharyngeal Neoplasms - virology Papillomavirus Infections - epidemiology Papillomavirus Infections - virology Penile Neoplasms - virology Penis Prevalence prevention Sex Characteristics Throat cancer United States - epidemiology Uterine Cervical Neoplasms - virology vaccine Vaccines Vagina Vulva attributable fraction vaccine cancer prevention human papillomavirus
Online Access	Get full text

Cover

Loading…

Abstract	HPV is the cause of almost all cervical cancer and is responsible for a substantial fraction of other anogenital cancers and oropharyngeal cancers. Understanding the HPV‐attributable cancer burden can boost programs of HPV vaccination and HPV‐based cervical screening. Attributable fractions (AFs) and the relative contributions of different HPV types were derived from published studies reporting on the prevalence of transforming HPV infection in cancer tissue. Maps of age‐standardized incidence rates of HPV‐attributable cancers by country from GLOBOCAN 2012 data are shown separately for the cervix, other anogenital tract and head and neck cancers. The relative contribution of HPV16/18 and HPV6/11/16/18/31/33/45/52/58 was also estimated. 4.5% of all cancers worldwide (630,000 new cancer cases per year) are attributable to HPV: 8.6% in women and 0.8% in men. AF in women ranges from <3% in Australia/New Zealand and the USA to >20% in India and sub‐Saharan Africa. Cervix accounts for 83% of HPV‐attributable cancer, two‐thirds of which occur in less developed countries. Other HPV‐attributable anogenital cancer includes 8,500 vulva; 12,000 vagina; 35,000 anus (half occurring in men) and 13,000 penis. In the head and neck, HPV‐attributable cancers represent 38,000 cases of which 21,000 are oropharyngeal cancers occurring in more developed countries. The relative contributions of HPV16/18 and HPV6/11/16/18/31/33/45/52/58 are 73% and 90%, respectively. Universal access to vaccination is the key to avoiding most cases of HPV‐attributable cancer. The preponderant burden of HPV16/18 and the possibility of cross‐protection emphasize the importance of the introduction of more affordable vaccines in less developed countries. What's new? Most cervical cancers result from human papillomavirus (HPV) infection and therefore are preventable through screening and vaccination. Nonetheless, efforts toward HPV‐attributable cancer prevention frequently are undermined by limited access to necessary resources. The present study estimates that worldwide as many as 4.5% of new cancer cases, including cancers of the cervix, anogenital tract and head and neck, are associated with HPV infection. Cervical cancer alone accounts for 83% of those cases, most of which affect women in less‐developed countries. The findings emphasize the importance of HPV screening and vaccination and the need for less‐costly vaccines.
AbstractList	HPV is the cause of almost all cervical cancer and is responsible for a substantial fraction of other anogenital cancers and oropharyngeal cancers. Understanding the HPV‐attributable cancer burden can boost programs of HPV vaccination and HPV‐based cervical screening. Attributable fractions (AFs) and the relative contributions of different HPV types were derived from published studies reporting on the prevalence of transforming HPV infection in cancer tissue. Maps of age‐standardized incidence rates of HPV‐attributable cancers by country from GLOBOCAN 2012 data are shown separately for the cervix, other anogenital tract and head and neck cancers. The relative contribution of HPV16/18 and HPV6/11/16/18/31/33/45/52/58 was also estimated. 4.5% of all cancers worldwide (630,000 new cancer cases per year) are attributable to HPV: 8.6% in women and 0.8% in men. AF in women ranges from <3% in Australia/New Zealand and the USA to >20% in India and sub‐Saharan Africa. Cervix accounts for 83% of HPV‐attributable cancer, two‐thirds of which occur in less developed countries. Other HPV‐attributable anogenital cancer includes 8,500 vulva; 12,000 vagina; 35,000 anus (half occurring in men) and 13,000 penis. In the head and neck, HPV‐attributable cancers represent 38,000 cases of which 21,000 are oropharyngeal cancers occurring in more developed countries. The relative contributions of HPV16/18 and HPV6/11/16/18/31/33/45/52/58 are 73% and 90%, respectively. Universal access to vaccination is the key to avoiding most cases of HPV‐attributable cancer. The preponderant burden of HPV16/18 and the possibility of cross‐protection emphasize the importance of the introduction of more affordable vaccines in less developed countries. What's new? Most cervical cancers result from human papillomavirus (HPV) infection and therefore are preventable through screening and vaccination. Nonetheless, efforts toward HPV‐attributable cancer prevention frequently are undermined by limited access to necessary resources. The present study estimates that worldwide as many as 4.5% of new cancer cases, including cancers of the cervix, anogenital tract and head and neck, are associated with HPV infection. Cervical cancer alone accounts for 83% of those cases, most of which affect women in less‐developed countries. The findings emphasize the importance of HPV screening and vaccination and the need for less‐costly vaccines. HPV is the cause of almost all cervical cancer and is responsible for a substantial fraction of other anogenital cancers and oropharyngeal cancers. Understanding the HPV-attributable cancer burden can boost programs of HPV vaccination and HPV-based cervical screening. Attributable fractions (AFs) and the relative contributions of different HPV types were derived from published studies reporting on the prevalence of transforming HPV infection in cancer tissue. Maps of age-standardized incidence rates of HPV-attributable cancers by country from GLOBOCAN 2012 data are shown separately for the cervix, other anogenital tract and head and neck cancers. The relative contribution of HPV16/18 and HPV6/11/16/18/31/33/45/52/58 was also estimated. 4.5% of all cancers worldwide (630,000 new cancer cases per year) are attributable to HPV: 8.6% in women and 0.8% in men. AF in women ranges from <3% in Australia/New Zealand and the USA to >20% in India and sub-Saharan Africa. Cervix accounts for 83% of HPV-attributable cancer, two-thirds of which occur in less developed countries. Other HPV-attributable anogenital cancer includes 8,500 vulva; 12,000 vagina; 35,000 anus (half occurring in men) and 13,000 penis. In the head and neck, HPV-attributable cancers represent 38,000 cases of which 21,000 are oropharyngeal cancers occurring in more developed countries. The relative contributions of HPV16/18 and HPV6/11/16/18/31/33/45/52/58 are 73% and 90%, respectively. Universal access to vaccination is the key to avoiding most cases of HPV-attributable cancer. The preponderant burden of HPV16/18 and the possibility of cross-protection emphasize the importance of the introduction of more affordable vaccines in less developed countries. What's new? Most cervical cancers result from human papillomavirus (HPV) infection and therefore are preventable through screening and vaccination. Nonetheless, efforts toward HPV-attributable cancer prevention frequently are undermined by limited access to necessary resources. The present study estimates that worldwide as many as 4.5% of new cancer cases, including cancers of the cervix, anogenital tract and head and neck, are associated with HPV infection. Cervical cancer alone accounts for 83% of those cases, most of which affect women in less-developed countries. The findings emphasize the importance of HPV screening and vaccination and the need for less-costly vaccines. HPV is the cause of almost all cervical cancer and is responsible for a substantial fraction of other anogenital cancers and oropharyngeal cancers. Understanding the HPV-attributable cancer burden can boost programs of HPV vaccination and HPV-based cervical screening. Attributable fractions (AFs) and the relative contributions of different HPV types were derived from published studies reporting on the prevalence of transforming HPV infection in cancer tissue. Maps of age-standardized incidence rates of HPV-attributable cancers by country from GLOBOCAN 2012 data are shown separately for the cervix, other anogenital tract and head and neck cancers. The relative contribution of HPV16/18 and HPV6/11/16/18/31/33/45/52/58 was also estimated. 4.5% of all cancers worldwide (630,000 new cancer cases per year) are attributable to HPV: 8.6% in women and 0.8% in men. AF in women ranges from <3% in Australia/New Zealand and the USA to >20% in India and sub-Saharan Africa. Cervix accounts for 83% of HPV-attributable cancer, two-thirds of which occur in less developed countries. Other HPV-attributable anogenital cancer includes 8,500 vulva; 12,000 vagina; 35,000 anus (half occurring in men) and 13,000 penis. In the head and neck, HPV-attributable cancers represent 38,000 cases of which 21,000 are oropharyngeal cancers occurring in more developed countries. The relative contributions of HPV16/18 and HPV6/11/16/18/31/33/45/52/58 are 73% and 90%, respectively. Universal access to vaccination is the key to avoiding most cases of HPV-attributable cancer. The preponderant burden of HPV16/18 and the possibility of cross-protection emphasize the importance of the introduction of more affordable vaccines in less developed countries. HPV is the cause of almost all cervical cancer and is responsible for a substantial fraction of other anogenital cancers and oropharyngeal cancers. Understanding the HPV-attributable cancer burden can boost programs of HPV vaccination and HPV-based cervical screening. Attributable fractions (AFs) and the relative contributions of different HPV types were derived from published studies reporting on the prevalence of transforming HPV infection in cancer tissue. Maps of age-standardized incidence rates of HPV-attributable cancers by country from GLOBOCAN 2012 data are shown separately for the cervix, other anogenital tract and head and neck cancers. The relative contribution of HPV16/18 and HPV6/11/16/18/31/33/45/52/58 was also estimated. 4.5% of all cancers worldwide (630,000 new cancer cases per year) are attributable to HPV: 8.6% in women and 0.8% in men. AF in women ranges from <3% in Australia/New Zealand and the USA to >20% in India and sub-Saharan Africa. Cervix accounts for 83% of HPV-attributable cancer, two-thirds of which occur in less developed countries. Other HPV-attributable anogenital cancer includes 8,500 vulva; 12,000 vagina; 35,000 anus (half occurring in men) and 13,000 penis. In the head and neck, HPV-attributable cancers represent 38,000 cases of which 21,000 are oropharyngeal cancers occurring in more developed countries. The relative contributions of HPV16/18 and HPV6/11/16/18/31/33/45/52/58 are 73% and 90%, respectively. Universal access to vaccination is the key to avoiding most cases of HPV-attributable cancer. The preponderant burden of HPV16/18 and the possibility of cross-protection emphasize the importance of the introduction of more affordable vaccines in less developed countries.HPV is the cause of almost all cervical cancer and is responsible for a substantial fraction of other anogenital cancers and oropharyngeal cancers. Understanding the HPV-attributable cancer burden can boost programs of HPV vaccination and HPV-based cervical screening. Attributable fractions (AFs) and the relative contributions of different HPV types were derived from published studies reporting on the prevalence of transforming HPV infection in cancer tissue. Maps of age-standardized incidence rates of HPV-attributable cancers by country from GLOBOCAN 2012 data are shown separately for the cervix, other anogenital tract and head and neck cancers. The relative contribution of HPV16/18 and HPV6/11/16/18/31/33/45/52/58 was also estimated. 4.5% of all cancers worldwide (630,000 new cancer cases per year) are attributable to HPV: 8.6% in women and 0.8% in men. AF in women ranges from <3% in Australia/New Zealand and the USA to >20% in India and sub-Saharan Africa. Cervix accounts for 83% of HPV-attributable cancer, two-thirds of which occur in less developed countries. Other HPV-attributable anogenital cancer includes 8,500 vulva; 12,000 vagina; 35,000 anus (half occurring in men) and 13,000 penis. In the head and neck, HPV-attributable cancers represent 38,000 cases of which 21,000 are oropharyngeal cancers occurring in more developed countries. The relative contributions of HPV16/18 and HPV6/11/16/18/31/33/45/52/58 are 73% and 90%, respectively. Universal access to vaccination is the key to avoiding most cases of HPV-attributable cancer. The preponderant burden of HPV16/18 and the possibility of cross-protection emphasize the importance of the introduction of more affordable vaccines in less developed countries.
Author	Franceschi, Silvia de Martel, Catherine Plummer, Martyn Vignat, Jerome
AuthorAffiliation	1 International Agency for Research on Cancer Lyon France
AuthorAffiliation_xml	– name: 1 International Agency for Research on Cancer Lyon France
Author_xml	– sequence: 1 givenname: Catherine orcidid: 0000-0002-3642-277X surname: de Martel fullname: de Martel, Catherine email: deMartelC@iarc.fr organization: International Agency for Research on Cancer – sequence: 2 givenname: Martyn surname: Plummer fullname: Plummer, Martyn organization: International Agency for Research on Cancer – sequence: 3 givenname: Jerome surname: Vignat fullname: Vignat, Jerome organization: International Agency for Research on Cancer – sequence: 4 givenname: Silvia surname: Franceschi fullname: Franceschi, Silvia organization: International Agency for Research on Cancer
BackLink	https://www.ncbi.nlm.nih.gov/pubmed/28369882$$D View this record in MEDLINE/PubMed
BookMark	eNp9kU9v1DAQxS3Uim4LB74AssQFJNKOndiJL0hoBbTVSnDgz9FynAl4lbW3tkOVb0-221ZQqZzm8H7z9GbeMTnwwSMhLxicMgB-5tb2tISaySdkwUDVBXAmDshi1qCoWSmPyHFKawDGBFRPyRFvSqmahi_I6keIQ3ftOqTtGDv0NPTUGm8xUpNzdO2YTTsgzYGef_lO24kml_EttWH0OU7U-O5GyNMWn5HD3gwJn9_OE_Lt44evy_Ni9fnTxfL9qrAClCy4KIWtOoNQSmBQ16VqK1N2wgKvkEPPqk5g3yqsWquUrPu6Fk3bGVYpUKIpT8i7ve92bDfYWZyTmEFvo9uYOOlgnP5X8e6X_hl-ayE4cL4zeH1rEMPViCnrjUsWh8F4DGPSrGkqJiVjckZfPUDXYYx-Pk8zNYfnIMsd9fLvRPdR7h49A2_2gI0hpYj9PcJA70rUc4n6psSZPXvAWpdNdmF3jBv-t3HtBpwet9YXl8v9xh-g6atp
CitedBy_id	crossref_primary_10_1186_s12903_024_04998_w crossref_primary_10_3390_vaccines9090940 crossref_primary_10_1093_annonc_mdx304 crossref_primary_10_3390_v13061008 crossref_primary_10_1016_j_snb_2019_01_056 crossref_primary_10_1007_s10461_024_04569_8 crossref_primary_10_1080_07853890_2024_2304649 crossref_primary_10_3390_biomedicines10112965 crossref_primary_10_1016_j_jvacx_2020_100066 crossref_primary_10_3390_vaccines8020181 crossref_primary_10_1016_j_heliyon_2024_e37959 crossref_primary_10_1016_j_phytochem_2020_112531 crossref_primary_10_4103_jiaphd_jiaphd_41_24 crossref_primary_10_1007_s40944_021_00552_6 crossref_primary_10_3390_cancers16010226 crossref_primary_10_2807_1560_7917_ES_2019_24_7_1700857 crossref_primary_10_1186_s13027_024_00581_8 crossref_primary_10_3390_ijerph192114010 crossref_primary_10_3390_vaccines7040157 crossref_primary_10_3390_vaccines11091435 crossref_primary_10_1016_S1470_2045_19_30531_5 crossref_primary_10_3389_fpubh_2024_1421636 crossref_primary_10_1016_j_virol_2019_08_021 crossref_primary_10_48175_IJARSCT_12064 crossref_primary_10_1016_j_revssu_2023_06_008 crossref_primary_10_3390_ijms23158566 crossref_primary_10_17116_molgen20213904139 crossref_primary_10_3390_ijms23158323 crossref_primary_10_1002_ohn_1056 crossref_primary_10_1007_s13337_019_00540_7 crossref_primary_10_1371_journal_pone_0278058 crossref_primary_10_1016_j_canep_2024_102646 crossref_primary_10_1007_s13224_021_01569_9 crossref_primary_10_3390_jcm10215209 crossref_primary_10_1007_s00761_018_0519_4 crossref_primary_10_3390_vaccines11091429 crossref_primary_10_1002_jmv_29280 crossref_primary_10_1080_21645515_2020_1808411 crossref_primary_10_1016_j_jsxm_2019_10_015 crossref_primary_10_3390_v12101119 crossref_primary_10_3390_cancers13246182 crossref_primary_10_1111_aos_14666 crossref_primary_10_1016_j_ymthe_2024_04_036 crossref_primary_10_1097_MD_0000000000031389 crossref_primary_10_1136_ijgc_2019_000582 crossref_primary_10_1093_infdis_jiy059 crossref_primary_10_1002_cam4_6008 crossref_primary_10_1111_cas_15105 crossref_primary_10_1016_j_prp_2024_155574 crossref_primary_10_3389_fgwh_2024_1400324 crossref_primary_10_1016_j_canep_2022_102099 crossref_primary_10_1016_j_currproblcancer_2022_100877 crossref_primary_10_1016_j_bbrc_2019_05_080 crossref_primary_10_3390_bios12100786 crossref_primary_10_1007_s13187_025_02610_5 crossref_primary_10_3390_pathogens12081013 crossref_primary_10_4103_IJOCR_IJOCR_17_24 crossref_primary_10_1002_jbt_22749 crossref_primary_10_2174_0115743624273536231105142321 crossref_primary_10_3923_ijv_2023_1_5 crossref_primary_10_3390_ijerph17124516 crossref_primary_10_3390_v15071573 crossref_primary_10_17816_pmj394144_154 crossref_primary_10_3389_fcimb_2024_1430424 crossref_primary_10_3390_diagnostics14060611 crossref_primary_10_1007_s11912_018_0698_6 crossref_primary_10_1016_j_ygeno_2020_08_025 crossref_primary_10_3390_cancers14010193 crossref_primary_10_1002_ijc_32709 crossref_primary_10_1080_21645515_2023_2239678 crossref_primary_10_1016_S2468_2667_20_30010_4 crossref_primary_10_1093_infdis_jiy067 crossref_primary_10_1159_000537760 crossref_primary_10_3802_jgo_2019_30_e50 crossref_primary_10_1002_jmv_29068 crossref_primary_10_1016_j_rpor_2019_08_006 crossref_primary_10_1128_mbio_00462_24 crossref_primary_10_1080_21645515_2025_2478705 crossref_primary_10_3389_frph_2023_1151179 crossref_primary_10_1136_ijgc_2021_002461 crossref_primary_10_3389_fonc_2022_864820 crossref_primary_10_1177_21582440231207451 crossref_primary_10_3390_pharmaceutics16050627 crossref_primary_10_1097_01_NURSE_0000531005_17471_7d crossref_primary_10_3390_cells13131107 crossref_primary_10_15406_jcpcr_2024_15_00560 crossref_primary_10_3389_fmolb_2021_677900 crossref_primary_10_1016_j_pvr_2017_12_004 crossref_primary_10_1016_j_ypmed_2019_04_006 crossref_primary_10_3389_fcimb_2022_996778 crossref_primary_10_1039_C9NR10334A crossref_primary_10_1016_j_pvr_2017_12_006 crossref_primary_10_1016_j_ygyno_2018_10_015 crossref_primary_10_26442_20795696_2019_2_190243 crossref_primary_10_3390_biom11050764 crossref_primary_10_1093_infdis_jiac437 crossref_primary_10_1093_jnci_djae320 crossref_primary_10_1200_GO_22_00441 crossref_primary_10_14639_0392_100X_suppl_1_40_2020 crossref_primary_10_3390_biom10020223 crossref_primary_10_3390_curroncol32030122 crossref_primary_10_3390_curroncol29080432 crossref_primary_10_1007_s10238_022_00796_2 crossref_primary_10_1016_j_vaccine_2018_08_009 crossref_primary_10_1080_14787210_2017_1392854 crossref_primary_10_1016_j_meegid_2020_104266 crossref_primary_10_1128_spectrum_01480_21 crossref_primary_10_1007_s00705_022_05589_2 crossref_primary_10_1080_21645515_2019_1565261 crossref_primary_10_1371_journal_ppat_1012837 crossref_primary_10_1186_s13027_021_00398_9 crossref_primary_10_1007_s42770_021_00602_3 crossref_primary_10_1016_j_jormas_2024_102134 crossref_primary_10_3390_microorganisms13040734 crossref_primary_10_1016_j_otc_2018_01_008 crossref_primary_10_1080_00918369_2022_2132574 crossref_primary_10_1080_0284186X_2021_1885059 crossref_primary_10_1155_2022_8548461 crossref_primary_10_1080_0284186X_2021_1885056 crossref_primary_10_1017_S0950268822000619 crossref_primary_10_3390_microorganisms7020054 crossref_primary_10_1016_j_micpath_2023_106302 crossref_primary_10_26633_RPSP_2023_72 crossref_primary_10_1016_j_canep_2023_102393 crossref_primary_10_1016_j_biopha_2019_109082 crossref_primary_10_1155_2019_6018269 crossref_primary_10_1002_mco2_43 crossref_primary_10_1016_j_tim_2019_10_008 crossref_primary_10_3389_fmicb_2019_02483 crossref_primary_10_1128_mbio_01811_24 crossref_primary_10_1155_2021_6641888 crossref_primary_10_1080_21645515_2022_2152256 crossref_primary_10_1016_j_currproblcancer_2018_06_005 crossref_primary_10_1016_j_currproblcancer_2018_06_004 crossref_primary_10_1002_1878_0261_13613 crossref_primary_10_1186_s12985_019_1175_z crossref_primary_10_1097_OR9_0000000000000068 crossref_primary_10_1016_j_prp_2019_152768 crossref_primary_10_1134_S0026893322050168 crossref_primary_10_1186_s13027_022_00445_z crossref_primary_10_1002_ijc_34919 crossref_primary_10_1038_s41598_020_71300_7 crossref_primary_10_1177_1073274819863802 crossref_primary_10_3390_vaccines12010016 crossref_primary_10_1016_j_cmi_2019_04_015 crossref_primary_10_1016_j_lanwpc_2023_100731 crossref_primary_10_1080_21645515_2025_2480404 crossref_primary_10_7554_eLife_75466 crossref_primary_10_1016_S1470_2045_22_00540_X crossref_primary_10_1016_S1470_2045_24_00016_0 crossref_primary_10_1002_ijc_31409 crossref_primary_10_3390_jcm12134216 crossref_primary_10_1093_infdis_jiz187 crossref_primary_10_1002_jmv_27903 crossref_primary_10_1038_s41418_022_00988_z crossref_primary_10_1093_jnci_djab080 crossref_primary_10_3389_fonc_2019_00213 crossref_primary_10_23736_S0026_4784_19_04443_5 crossref_primary_10_1136_bmjopen_2021_059968 crossref_primary_10_1080_21645515_2022_2105067 crossref_primary_10_1186_s12889_023_15876_5 crossref_primary_10_1038_s41598_020_66323_z crossref_primary_10_1186_s12889_022_13088_x crossref_primary_10_1038_s41598_019_55014_z crossref_primary_10_1016_j_ctarc_2021_100392 crossref_primary_10_3390_pathogens9050403 crossref_primary_10_3390_vaccines11050946 crossref_primary_10_1016_j_canep_2021_101925 crossref_primary_10_61622_rbgo_2024rbgo57 crossref_primary_10_1158_2326_6066_CIR_22_0454 crossref_primary_10_1002_ijc_31412 crossref_primary_10_1016_j_meegid_2019_103990 crossref_primary_10_1093_infdis_jiz191 crossref_primary_10_1007_s13538_021_01033_z crossref_primary_10_1016_j_ejso_2022_03_232 crossref_primary_10_1186_s12962_021_00328_x crossref_primary_10_1016_j_eclinm_2022_101585 crossref_primary_10_1097_MD9_0000000000000299 crossref_primary_10_1038_s41598_019_41102_7 crossref_primary_10_1080_21645515_2020_1761202 crossref_primary_10_1016_j_vaccine_2019_02_020 crossref_primary_10_3389_fcimb_2022_1103505 crossref_primary_10_1016_j_jcvp_2022_100105 crossref_primary_10_1200_GO_23_00464 crossref_primary_10_1111_cas_16230 crossref_primary_10_3390_cancers10120493 crossref_primary_10_1128_jvi_01640_24 crossref_primary_10_1080_13557858_2022_2116630 crossref_primary_10_1016_j_pedn_2024_07_016 crossref_primary_10_1177_03000605211022534 crossref_primary_10_1177_0956462419878039 crossref_primary_10_1016_j_ygyno_2021_10_073 crossref_primary_10_3390_vaccines8030391 crossref_primary_10_1159_000509669 crossref_primary_10_1038_s41416_023_02227_9 crossref_primary_10_1016_j_oooo_2024_10_082 crossref_primary_10_1111_bcp_14502 crossref_primary_10_1016_S2214_109X_20_30358_2 crossref_primary_10_1038_s41598_023_48721_1 crossref_primary_10_2174_0929867329666220301114251 crossref_primary_10_1038_s41598_020_79963_y crossref_primary_10_1007_s10103_024_04129_5 crossref_primary_10_3390_cancers15153786 crossref_primary_10_1002_jmv_27012 crossref_primary_10_2147_CLEP_S293929 crossref_primary_10_3390_pathogens12020252 crossref_primary_10_1016_j_cca_2023_117269 crossref_primary_10_3389_fphar_2021_628434 crossref_primary_10_1016_j_pathol_2019_10_008 crossref_primary_10_3390_cancers12010253 crossref_primary_10_1016_j_pmedr_2020_101289 crossref_primary_10_1038_s41598_019_49061_9 crossref_primary_10_1371_journal_pone_0311137 crossref_primary_10_7883_yoken_JJID_2018_206 crossref_primary_10_7883_yoken_JJID_2018_448 crossref_primary_10_1007_s11010_020_03941_1 crossref_primary_10_3389_fimmu_2022_1055235 crossref_primary_10_1016_j_vaccine_2019_12_013 crossref_primary_10_3802_jgo_2024_35_e58 crossref_primary_10_1073_pnas_2118930119 crossref_primary_10_21876_rcshci_v11i1_1021 crossref_primary_10_1016_j_vaccine_2019_12_016 crossref_primary_10_1016_j_ypmed_2024_107941 crossref_primary_10_1186_s13027_018_0181_x crossref_primary_10_1016_j_jmoldx_2020_08_002 crossref_primary_10_1556_650_2023_32871 crossref_primary_10_1093_infdis_jiaa065 crossref_primary_10_1038_s41598_021_00368_6 crossref_primary_10_3390_v13102045 crossref_primary_10_4103_PMRR_PMRR_16_23 crossref_primary_10_1002_cncr_34148 crossref_primary_10_1093_cid_ciy1012 crossref_primary_10_1002_jmv_27020 crossref_primary_10_1002_jmv_28351 crossref_primary_10_1080_21645515_2023_2207441 crossref_primary_10_3390_diagnostics11060952 crossref_primary_10_1016_j_ebiom_2021_103222 crossref_primary_10_3389_fmed_2023_1224400 crossref_primary_10_1128_mBio_02323_18 crossref_primary_10_1128_mSphere_00049_20 crossref_primary_10_1007_s00404_024_07497_z crossref_primary_10_1177_1724600818768459 crossref_primary_10_1016_j_pmedr_2019_101010 crossref_primary_10_1186_s12885_019_6264_2 crossref_primary_10_1042_BST20221067 crossref_primary_10_1080_22221751_2024_2313848 crossref_primary_10_15570_actaapa_2018_26 crossref_primary_10_2222_jsv_74_17 crossref_primary_10_3390_healthcare11030325 crossref_primary_10_34084_bshr_1455863 crossref_primary_10_1016_S2352_3018_21_00108_9 crossref_primary_10_3390_life10110290 crossref_primary_10_1016_j_antiviral_2019_03_012 crossref_primary_10_3389_fonc_2021_640036 crossref_primary_10_1016_j_eclinm_2021_100836 crossref_primary_10_1186_s12915_019_0678_9 crossref_primary_10_1016_j_oraloncology_2020_104736 crossref_primary_10_1080_21645515_2023_2229222 crossref_primary_10_3389_fmolb_2022_875208 crossref_primary_10_1007_s13187_019_01683_3 crossref_primary_10_3390_pathogens12040564 crossref_primary_10_1007_s13193_020_01200_9 crossref_primary_10_3389_fonc_2023_1257401 crossref_primary_10_1002_ijc_32544 crossref_primary_10_1093_cid_ciy1040 crossref_primary_10_1002_ijc_33876 crossref_primary_10_1097_MD_0000000000014436 crossref_primary_10_1097_MD_0000000000039957 crossref_primary_10_1016_j_bbrc_2019_06_058 crossref_primary_10_1016_j_coph_2022_102309 crossref_primary_10_3389_fonc_2024_1331862 crossref_primary_10_3390_microorganisms12030619 crossref_primary_10_1002_jmv_29465 crossref_primary_10_1007_s10935_022_00697_w crossref_primary_10_1016_j_tvr_2021_200233 crossref_primary_10_1016_j_antiviral_2024_106035 crossref_primary_10_1021_acsami_9b04147 crossref_primary_10_1002_cncy_22267 crossref_primary_10_1007_s11864_019_0650_5 crossref_primary_10_3390_cancers14235785 crossref_primary_10_4132_jptm_2020_06_22 crossref_primary_10_1016_j_pmedr_2022_101813 crossref_primary_10_12677_AMB_2020_93015 crossref_primary_10_1007_s10989_021_10285_x crossref_primary_10_1016_S1473_3099_19_30164_1 crossref_primary_10_4014_jmb_2408_08041 crossref_primary_10_1016_j_heliyon_2025_e42548 crossref_primary_10_1371_journal_pone_0264498 crossref_primary_10_1007_s00432_020_03218_6 crossref_primary_10_1200_GO_20_00303 crossref_primary_10_2139_ssrn_4128886 crossref_primary_10_1093_jncics_pkad012 crossref_primary_10_1080_21645515_2023_2184605 crossref_primary_10_1001_jamaoncol_2024_6998 crossref_primary_10_3724_abbs_2025022 crossref_primary_10_3389_fonc_2023_1219161 crossref_primary_10_1111_cas_15528 crossref_primary_10_1038_s41423_022_00897_8 crossref_primary_10_1186_s12985_024_02397_9 crossref_primary_10_3389_fsurg_2021_833048 crossref_primary_10_1186_s13059_023_02926_9 crossref_primary_10_1016_S0992_5945_24_00275_7 crossref_primary_10_1080_21645515_2021_2007709 crossref_primary_10_1136_bmjopen_2018_026887 crossref_primary_10_1186_s12967_025_06277_w crossref_primary_10_1136_fmch_2019_000182 crossref_primary_10_1016_j_tvr_2022_200245 crossref_primary_10_1186_s12985_023_02221_w crossref_primary_10_3389_fgwh_2022_871090 crossref_primary_10_1016_j_pmedr_2021_101521 crossref_primary_10_3389_fonc_2020_01651 crossref_primary_10_1038_s41598_019_42393_6 crossref_primary_10_1002_ijc_32791 crossref_primary_10_1371_journal_pcbi_1009352 crossref_primary_10_1002_jmv_29230 crossref_primary_10_7774_cevr_2024_13_1_21 crossref_primary_10_1093_cid_ciab157 crossref_primary_10_1016_j_cct_2021_106631 crossref_primary_10_1055_s_0041_1740601 crossref_primary_10_1111_cyt_12911 crossref_primary_10_1002_bab_2128 crossref_primary_10_2147_CMAR_S244317 crossref_primary_10_1371_journal_pone_0291643 crossref_primary_10_1158_1055_9965_EPI_18_0322 crossref_primary_10_3390_pathogens10101224 crossref_primary_10_3390_vaccines10111976 crossref_primary_10_1038_s41541_022_00539_0 crossref_primary_10_1016_j_vaccine_2019_11_027 crossref_primary_10_1016_j_tvr_2022_200237 crossref_primary_10_3389_fimmu_2021_593161 crossref_primary_10_1016_j_disamonth_2020_101103 crossref_primary_10_1097_OLQ_0000000000001097 crossref_primary_10_1128_mSphere_00129_19 crossref_primary_10_3390_pathogens12121380 crossref_primary_10_1111_jop_12779 crossref_primary_10_24931_2413_9432_2023_13_1_47_55 crossref_primary_10_1200_GO_23_00408 crossref_primary_10_1016_j_cct_2021_106629 crossref_primary_10_1371_journal_pone_0227900 crossref_primary_10_3390_cancers15143713 crossref_primary_10_1186_s42826_023_00166_3 crossref_primary_10_3390_cancers13235889 crossref_primary_10_4155_bio_2017_0176 crossref_primary_10_1016_j_revmed_2024_11_001 crossref_primary_10_3322_caac_21763 crossref_primary_10_3390_diagnostics14171986 crossref_primary_10_1093_infdis_jiad109 crossref_primary_10_1002_lary_28026 crossref_primary_10_1080_13696998_2023_2250194 crossref_primary_10_1186_s12985_021_01529_9 crossref_primary_10_12677_acm_2025_151059 crossref_primary_10_1007_s00431_024_05910_y crossref_primary_10_1186_s12985_024_02518_4 crossref_primary_10_1016_j_vaccine_2021_08_043 crossref_primary_10_1016_j_pdpdt_2021_102517 crossref_primary_10_1128_jvi_00643_23 crossref_primary_10_1002_cac2_70000 crossref_primary_10_7759_cureus_72435 crossref_primary_10_2174_1573405618666220428104541 crossref_primary_10_2807_1560_7917_ES_2021_26_50_2001965 crossref_primary_10_3389_fpubh_2019_00004 crossref_primary_10_1016_j_eclinm_2024_102878 crossref_primary_10_1186_s12889_024_19792_0 crossref_primary_10_1007_s00120_018_0810_4 crossref_primary_10_3390_v13010022 crossref_primary_10_7554_eLife_81752 crossref_primary_10_1007_s40265_023_01835_2 crossref_primary_10_3390_tropicalmed8120511 crossref_primary_10_3390_cancers10070213 crossref_primary_10_1016_j_critrevonc_2024_104346 crossref_primary_10_1016_j_jviromet_2021_114218 crossref_primary_10_1158_0008_5472_CAN_21_2101 crossref_primary_10_1101_gr_275911_121 crossref_primary_10_2174_0118715265257105231025112708 crossref_primary_10_1016_j_antinf_2017_10_002 crossref_primary_10_1038_s41598_019_40094_8 crossref_primary_10_3390_cancers14235742 crossref_primary_10_3390_microorganisms9051001 crossref_primary_10_1002_ijc_34763 crossref_primary_10_1016_j_virol_2023_02_007 crossref_primary_10_1016_j_vaccine_2019_11_044 crossref_primary_10_3390_cancers13225602 crossref_primary_10_1007_s11427_019_9547_7 crossref_primary_10_1080_03630242_2020_1831683 crossref_primary_10_1016_j_amepre_2019_12_003 crossref_primary_10_1021_acs_analchem_1c00035 crossref_primary_10_1097_QAI_0000000000002258 crossref_primary_10_3390_vaccines13010092 crossref_primary_10_3390_vaccines8020175 crossref_primary_10_1089_whr_2024_0004 crossref_primary_10_1186_s12985_022_01879_y crossref_primary_10_1097_CJI_0000000000000386 crossref_primary_10_1097_INF_0000000000002437 crossref_primary_10_3390_pathogens12070908 crossref_primary_10_1056_NEJMsr2210097 crossref_primary_10_3892_mmr_2019_10847 crossref_primary_10_1080_15321819_2024_2441778 crossref_primary_10_2147_AHMT_S383872 crossref_primary_10_3390_v14061212 crossref_primary_10_1016_j_revssu_2024_04_008 crossref_primary_10_1080_03630242_2020_1822490 crossref_primary_10_4251_wjgo_v13_i12_1956 crossref_primary_10_1097_LGT_0000000000000750 crossref_primary_10_1186_s13046_019_1268_y crossref_primary_10_1002_pmic_201700390 crossref_primary_10_3390_cancers12092516 crossref_primary_10_1016_j_ijid_2023_07_003 crossref_primary_10_3389_fimmu_2022_1005937 crossref_primary_10_7717_peerj_8516 crossref_primary_10_1080_14760584_2024_2402535 crossref_primary_10_3389_fonc_2023_1128753 crossref_primary_10_1016_j_jval_2020_07_012 crossref_primary_10_3390_cancers12102997 crossref_primary_10_1002_cam4_6916 crossref_primary_10_3390_vaccines12020205 crossref_primary_10_3390_diagnostics12081906 crossref_primary_10_3390_v13112234 crossref_primary_10_1111_aogs_13424 crossref_primary_10_1016_j_vaccine_2018_12_030 crossref_primary_10_1007_s10389_023_02089_8 crossref_primary_10_1038_s41388_025_03310_6 crossref_primary_10_1093_infdis_jiy715 crossref_primary_10_1128_mbio_00696_23 crossref_primary_10_3389_fpubh_2022_922587 crossref_primary_10_1007_s10238_024_01470_5 crossref_primary_10_1016_j_jpba_2019_112989 crossref_primary_10_3390_healthcare11233010 crossref_primary_10_3390_medicina58060806 crossref_primary_10_3390_cancers14194623 crossref_primary_10_26508_lsa_202302448 crossref_primary_10_1186_s12889_020_09161_y crossref_primary_10_3390_ijms24043344 crossref_primary_10_1016_j_micpath_2022_105747 crossref_primary_10_3389_fimmu_2020_00188 crossref_primary_10_1097_CEJ_0000000000000753 crossref_primary_10_7759_cureus_57120 crossref_primary_10_1016_j_pedn_2017_12_003 crossref_primary_10_1016_j_vaccine_2023_08_047 crossref_primary_10_3390_vaccines10060930 crossref_primary_10_1016_j_pedhc_2022_02_001 crossref_primary_10_1002_wsbm_1539 crossref_primary_10_3390_vaccines12111239 crossref_primary_10_1002_hed_25557 crossref_primary_10_1016_j_canep_2018_12_003 crossref_primary_10_1016_j_canep_2018_12_004 crossref_primary_10_54393_nrs_v1i01_2 crossref_primary_10_1097_INF_0000000000002659 crossref_primary_10_3389_frph_2021_695254 crossref_primary_10_1128_JVI_01024_20 crossref_primary_10_3390_cancers13040832 crossref_primary_10_2174_1573404818666220304104128 crossref_primary_10_1080_14737159_2025_2451717 crossref_primary_10_5468_ogs_21123 crossref_primary_10_1038_s41598_020_80193_5 crossref_primary_10_1016_j_ejogrb_2023_02_003 crossref_primary_10_1021_acs_jproteome_9b00139 crossref_primary_10_1097_CEJ_0000000000000761 crossref_primary_10_1002_advs_202205217 crossref_primary_10_1136_jitc_2020_000612 crossref_primary_10_1002_jmv_29741 crossref_primary_10_1038_s41598_021_83489_2 crossref_primary_10_1002_jmv_29746 crossref_primary_10_1016_j_coviro_2019_06_006 crossref_primary_10_14777_uti_2448030015 crossref_primary_10_1016_S2352_4642_21_00278_9 crossref_primary_10_2147_ITT_S273327 crossref_primary_10_1016_j_molimm_2024_05_006 crossref_primary_10_1016_j_jinf_2021_02_017 crossref_primary_10_1128_jcm_01403_22 crossref_primary_10_1016_j_lpmfor_2024_01_011 crossref_primary_10_1038_s41541_025_01106_z crossref_primary_10_1080_21645515_2023_2209001 crossref_primary_10_1007_s11864_023_01165_1 crossref_primary_10_1016_j_adaj_2020_11_012 crossref_primary_10_1111_ddg_15294 crossref_primary_10_1016_j_semradonc_2021_04_001 crossref_primary_10_1016_j_jasc_2023_11_002 crossref_primary_10_1111_dth_14744 crossref_primary_10_3390_jcm10091911 crossref_primary_10_1097_OLQ_0000000000001916 crossref_primary_10_3389_fpubh_2023_1128717 crossref_primary_10_4236_jbm_2023_119015 crossref_primary_10_1080_21645515_2022_2052700 crossref_primary_10_3390_cancers16213556 crossref_primary_10_47470_0044_197X_2021_65_6_573_580 crossref_primary_10_1111_tra_12931 crossref_primary_10_3390_vaccines11071175 crossref_primary_10_1093_eurpub_ckz113 crossref_primary_10_1177_17455065211055304 crossref_primary_10_1186_s12939_024_02199_z crossref_primary_10_1099_jgv_0_001540 crossref_primary_10_3390_microorganisms11051163 crossref_primary_10_1038_s41598_023_48222_1 crossref_primary_10_1093_humrep_deae139 crossref_primary_10_1016_j_vaccine_2024_02_076 crossref_primary_10_1158_1055_9965_EPI_21_1256 crossref_primary_10_1016_j_oraloncology_2020_104958 crossref_primary_10_1002_cncy_22295 crossref_primary_10_1016_j_amjoto_2022_103614 crossref_primary_10_1016_j_bbrc_2020_05_183 crossref_primary_10_2147_JMDH_S438633 crossref_primary_10_61186_payesh_22_6_771 crossref_primary_10_1038_s41525_024_00418_8 crossref_primary_10_1016_j_tranon_2021_101084 crossref_primary_10_1093_infdis_jiaa709 crossref_primary_10_1111_1348_0421_12927 crossref_primary_10_33667_2078_5631_2024_8_57_61 crossref_primary_10_36740_WLek202312119 crossref_primary_10_1016_j_adcanc_2023_100097 crossref_primary_10_1007_s11845_024_03715_4 crossref_primary_10_1016_j_pvr_2019_04_012 crossref_primary_10_1186_s13027_020_00283_x crossref_primary_10_3390_ijerph191711032 crossref_primary_10_35627_2219_5238_2022_30_8_73_81 crossref_primary_10_1111_petr_14341 crossref_primary_10_3390_v13020321 crossref_primary_10_3390_v15061296 crossref_primary_10_1080_01443615_2022_2049717 crossref_primary_10_1007_s12026_021_09196_2 crossref_primary_10_1080_21645515_2020_1756670 crossref_primary_10_1093_cid_ciab429 crossref_primary_10_1038_s41388_020_01431_8 crossref_primary_10_1136_sextrans_2024_056361 crossref_primary_10_1186_s43046_023_00196_x crossref_primary_10_2139_ssrn_4175216 crossref_primary_10_1016_j_nurpra_2021_09_024 crossref_primary_10_17231_comsoc_46_2024__5682 crossref_primary_10_1080_21645515_2019_1691413 crossref_primary_10_1093_infdis_jiz623 crossref_primary_10_1021_acs_analchem_3c01723 crossref_primary_10_1177_00099228251324017 crossref_primary_10_1186_s12985_021_01657_2 crossref_primary_10_1155_2020_7926754 crossref_primary_10_1016_j_bbagrm_2019_01_001 crossref_primary_10_1136_bmj_m4931 crossref_primary_10_3390_nu13124529 crossref_primary_10_1080_14760584_2019_1568876 crossref_primary_10_1093_jncics_pky045 crossref_primary_10_1007_s00103_018_2791_2 crossref_primary_10_1016_S1473_3099_17_30653_9 crossref_primary_10_3238_arztebl_m2024_0062 crossref_primary_10_3390_v15041005 crossref_primary_10_2298_VSP200727058M crossref_primary_10_1016_j_vaccine_2025_126868 crossref_primary_10_3389_fonc_2022_807597 crossref_primary_10_3390_biology13040227 crossref_primary_10_1080_20477724_2024_2401273 crossref_primary_10_1016_j_vaccine_2023_09_054 crossref_primary_10_2139_ssrn_4046139 crossref_primary_10_1007_s10142_019_00706_y crossref_primary_10_1371_journal_pgph_0004245 crossref_primary_10_3390_cancers12071803 crossref_primary_10_1186_s13027_018_0185_6 crossref_primary_10_1002_jmv_28208 crossref_primary_10_1042_BSR20203669 crossref_primary_10_3389_fpubh_2024_1357606 crossref_primary_10_1093_heapol_czaa017 crossref_primary_10_1002_jmv_70190 crossref_primary_10_1371_journal_pone_0232871 crossref_primary_10_3390_ijms252312991 crossref_primary_10_3233_THC_212890 crossref_primary_10_1177_10732748251318386 crossref_primary_10_3390_v13061091 crossref_primary_10_1007_s00784_020_03698_3 crossref_primary_10_1016_j_bulcan_2017_12_001 crossref_primary_10_1186_s12903_025_05724_w crossref_primary_10_5937_bjdm2301038A crossref_primary_10_1016_S1470_2045_20_30524_6 crossref_primary_10_1038_s41594_024_01456_7 crossref_primary_10_1007_s00430_020_00683_1 crossref_primary_10_1186_s12978_023_01711_y crossref_primary_10_4103_ijmr_IJMR_386_19 crossref_primary_10_1007_s11033_023_08939_8 crossref_primary_10_1016_j_det_2019_10_005 crossref_primary_10_1016_j_ebiom_2023_104577 crossref_primary_10_3389_fonc_2021_765640 crossref_primary_10_3892_mco_2020_2043 crossref_primary_10_1080_14760584_2022_2125383 crossref_primary_10_1098_rstb_2018_0289 crossref_primary_10_3390_ijerph19020914 crossref_primary_10_1097_MD_0000000000032651 crossref_primary_10_7717_peerj_15878 crossref_primary_10_1016_j_coviro_2019_07_008 crossref_primary_10_9745_GHSP_D_18_00222 crossref_primary_10_1002_jmv_27921 crossref_primary_10_1016_j_banm_2022_10_019 crossref_primary_10_1186_s12879_018_3645_0 crossref_primary_10_3390_cancers13215383 crossref_primary_10_3389_fonc_2023_1226202 crossref_primary_10_3389_fpubh_2020_552028 crossref_primary_10_1016_j_ad_2024_10_006 crossref_primary_10_1080_01443615_2024_2311658 crossref_primary_10_15407_ubj96_05_119 crossref_primary_10_1080_21645515_2025_2474891 crossref_primary_10_1016_j_oraloncology_2018_06_010 crossref_primary_10_1002_dc_24925 crossref_primary_10_1038_s41416_024_02655_1 crossref_primary_10_1093_jnci_djz074 crossref_primary_10_1098_rstb_2018_0298 crossref_primary_10_3390_jpm13091397 crossref_primary_10_1016_j_vaccine_2019_08_053 crossref_primary_10_1093_cid_ciaa781 crossref_primary_10_1111_aogs_14913 crossref_primary_10_1155_2020_8838317 crossref_primary_10_1002_cbin_11744 crossref_primary_10_1186_s12985_018_1003_x crossref_primary_10_7717_peerj_10179 crossref_primary_10_3389_fimmu_2021_645299 crossref_primary_10_3390_microorganisms11061609 crossref_primary_10_1007_s12105_025_01752_8 crossref_primary_10_1136_sextrans_2022_055504 crossref_primary_10_4069_kjwhn_2020_03_07 crossref_primary_10_1038_s41416_020_0964_x crossref_primary_10_1002_ijc_33055 crossref_primary_10_3346_jkms_2025_40_e95 crossref_primary_10_1111_jeb_13958 crossref_primary_10_1016_j_canep_2018_10_008 crossref_primary_10_1186_s12985_024_02393_z crossref_primary_10_12688_aasopenres_12910_5 crossref_primary_10_52979_raoa_1196 crossref_primary_10_12688_aasopenres_12910_3 crossref_primary_10_1016_j_cmi_2018_04_019 crossref_primary_10_12688_aasopenres_12910_4 crossref_primary_10_3390_cancers13061368 crossref_primary_10_1016_j_epidem_2023_100707 crossref_primary_10_1111_cyt_12581 crossref_primary_10_1002_cam4_2720 crossref_primary_10_1128_cmr_00085_23 crossref_primary_10_1126_sciadv_adc9830 crossref_primary_10_1080_07853890_2021_1938201 crossref_primary_10_1038_s41416_018_0049_2 crossref_primary_10_3390_diagnostics14212379 crossref_primary_10_1016_j_canep_2019_101593 crossref_primary_10_1200_PO_18_00276 crossref_primary_10_1371_journal_pone_0253735 crossref_primary_10_3389_fonc_2022_857445 crossref_primary_10_1080_13543784_2023_2179483 crossref_primary_10_1093_heapro_daad153 crossref_primary_10_1016_j_abb_2022_109389 crossref_primary_10_1007_s00105_020_04669_1 crossref_primary_10_1016_j_vaccine_2025_126827 crossref_primary_10_1007_s13669_021_00319_y crossref_primary_10_1093_ije_dyy140 crossref_primary_10_12688_aasopenres_12910_2 crossref_primary_10_1186_s12889_020_08545_4 crossref_primary_10_3389_fimmu_2024_1430544 crossref_primary_10_3390_tropicalmed10030061 crossref_primary_10_1371_journal_ppat_1012454 crossref_primary_10_1016_j_vaccine_2025_126841 crossref_primary_10_1186_s12957_023_02907_z crossref_primary_10_1007_s40136_023_00448_3 crossref_primary_10_1007_s13577_020_00447_2 crossref_primary_10_1186_s12917_019_1971_0 crossref_primary_10_1177_0969141319885409 crossref_primary_10_3390_ijms21145020 crossref_primary_10_1186_s13027_018_0187_4 crossref_primary_10_3389_fonc_2020_528957 crossref_primary_10_1002_path_5475 crossref_primary_10_3390_cells12091323 crossref_primary_10_3390_ijms23137465 crossref_primary_10_1080_01635581_2021_1936082 crossref_primary_10_2147_IJWH_S380385 crossref_primary_10_5812_apid_140119 crossref_primary_10_1002_cncr_32986 crossref_primary_10_1128_JVI_02032_20 crossref_primary_10_1155_2018_6583852 crossref_primary_10_1002_mma_10529 crossref_primary_10_1097_OLQ_0000000000001356 crossref_primary_10_1093_cid_ciab603 crossref_primary_10_1097_NCC_0000000000000608 crossref_primary_10_1038_s41416_019_0422_9 crossref_primary_10_1097_MD_0000000000032855 crossref_primary_10_3390_ijms23158132 crossref_primary_10_7759_cureus_57701 crossref_primary_10_3390_cancers13143483 crossref_primary_10_1186_s12905_023_02669_6 crossref_primary_10_1038_s41571_022_00603_7 crossref_primary_10_3390_v13112207 crossref_primary_10_7586_jkbns_25_001 crossref_primary_10_1057_s41599_024_03644_8 crossref_primary_10_1002_elan_202100276 crossref_primary_10_1200_GO_21_00082 crossref_primary_10_23736_S2724_606X_22_04956_9 crossref_primary_10_1007_s12070_024_04917_z crossref_primary_10_1007_s12094_023_03087_8 crossref_primary_10_1158_1940_6207_CAPR_19_0098 crossref_primary_10_3390_jcm12124024 crossref_primary_10_3390_ijerph22030439 crossref_primary_10_1292_jvms_23_0322 crossref_primary_10_1039_D3CC05949A crossref_primary_10_1128_JVI_00730_20 crossref_primary_10_21101_cejph_a7257 crossref_primary_10_1002_jmv_27978 crossref_primary_10_3390_vaccines12111262 crossref_primary_10_1002_jmv_25556 crossref_primary_10_1136_sextrans_2018_053742 crossref_primary_10_3390_vaccines10020228 crossref_primary_10_1016_S1773_035X_21_00070_8 crossref_primary_10_3390_v15122411 crossref_primary_10_1016_S1470_2045_18_30682_X crossref_primary_10_1080_21645515_2024_2425535 crossref_primary_10_1136_sextrans_2021_055009 crossref_primary_10_1002_cncr_35830 crossref_primary_10_1097_LGT_0000000000000723 crossref_primary_10_3390_v16111751 crossref_primary_10_1002_cam4_4091 crossref_primary_10_1007_s13337_022_00776_w crossref_primary_10_1158_1078_0432_CCR_18_2722 crossref_primary_10_1038_s41379_020_0637_6 crossref_primary_10_1016_j_vaccine_2025_126817 crossref_primary_10_2217_fon_2020_0389 crossref_primary_10_1038_s44222_023_00135_4 crossref_primary_10_1186_s13027_021_00360_9 crossref_primary_10_1016_j_ypmed_2022_106960 crossref_primary_10_1371_journal_pone_0290088 crossref_primary_10_1080_1744666X_2021_1886924 crossref_primary_10_1128_mbio_02033_22 crossref_primary_10_1021_acs_analchem_3c05497 crossref_primary_10_3390_vaccines10020239 crossref_primary_10_1007_s11654_020_00258_9 crossref_primary_10_1186_s12885_021_08787_4 crossref_primary_10_1016_j_addr_2021_113956 crossref_primary_10_1166_jbt_2022_2970 crossref_primary_10_1007_s40136_021_00385_z crossref_primary_10_1038_s41598_022_13442_4 crossref_primary_10_1038_s41598_022_22438_z crossref_primary_10_3390_ijms242317056 crossref_primary_10_1038_s41388_025_03295_2 crossref_primary_10_1097_QAI_0000000000002941 crossref_primary_10_1016_j_sbsr_2023_100562 crossref_primary_10_2217_bmm_2018_0441 crossref_primary_10_1007_s40258_020_00576_7 crossref_primary_10_1016_j_ypmed_2020_106354 crossref_primary_10_1016_j_bulcan_2020_04_016 crossref_primary_10_3390_vaccines8040568 crossref_primary_10_1016_j_bbadis_2021_166172 crossref_primary_10_1371_journal_pone_0235065 crossref_primary_10_1007_s13187_021_02090_3 crossref_primary_10_1371_journal_pone_0294698 crossref_primary_10_1016_j_oraloncology_2020_105177 crossref_primary_10_1186_s13027_024_00609_z crossref_primary_10_3390_vaccines12111286 crossref_primary_10_3103_S0891416821040066 crossref_primary_10_1016_j_pvr_2019_02_001 crossref_primary_10_1016_j_pvr_2019_02_003 crossref_primary_10_1136_bmjopen_2023_076234 crossref_primary_10_1098_rsob_210004 crossref_primary_10_1177_2473974X18818415 crossref_primary_10_2485_jhtb_32_77 crossref_primary_10_1186_s12879_022_07251_3 crossref_primary_10_3390_microorganisms9102092 crossref_primary_10_1089_whr_2023_0153 crossref_primary_10_1016_j_oraloncology_2022_105776 crossref_primary_10_1016_j_tips_2024_07_004 crossref_primary_10_1158_1078_0432_CCR_18_2984 crossref_primary_10_3390_v13122455 crossref_primary_10_1111_ajco_13513 crossref_primary_10_1136_bmjopen_2020_040645 crossref_primary_10_1136_practneurol_2020_002527 crossref_primary_10_1556_030_2022_01794 crossref_primary_10_1007_s10552_021_01510_5 crossref_primary_10_3390_ijerph18178938 crossref_primary_10_1007_s00103_021_03316_x crossref_primary_10_1186_s12905_021_01510_2 crossref_primary_10_3390_v11040369 crossref_primary_10_1007_s40944_019_0284_3 crossref_primary_10_1097_GRF_0000000000000789 crossref_primary_10_1016_j_virol_2023_109946 crossref_primary_10_37871_jbres1341 crossref_primary_10_1038_s41579_021_00617_5 crossref_primary_10_1038_s41392_024_02083_w crossref_primary_10_1177_1745506520961709 crossref_primary_10_3390_cancers11020138 crossref_primary_10_1002_cnr2_1873 crossref_primary_10_1080_2162402X_2018_1524694 crossref_primary_10_3389_fpubh_2022_1010237 crossref_primary_10_4143_crt_2019_053 crossref_primary_10_1007_s11042_021_10627_3 crossref_primary_10_1080_21645515_2023_2266935 crossref_primary_10_3390_biology13020077 crossref_primary_10_1136_bmjopen_2023_074787 crossref_primary_10_3390_cancers13051173 crossref_primary_10_1186_s13027_021_00397_w crossref_primary_10_1200_JGO_19_00242 crossref_primary_10_1002_cncr_33346 crossref_primary_10_1002_jmv_29155 crossref_primary_10_1097_JNC_0000000000000240 crossref_primary_10_15690_vramn1212 crossref_primary_10_3389_fonc_2020_581208 crossref_primary_10_1111_hiv_13684 crossref_primary_10_1038_s41598_018_38378_6 crossref_primary_10_1093_jambio_lxae184 crossref_primary_10_3390_vaccines10071054 crossref_primary_10_1002_jmv_24943 crossref_primary_10_1080_21645515_2023_2184756 crossref_primary_10_1080_21645515_2024_2334474 crossref_primary_10_3390_ijms232012371 crossref_primary_10_12677_ACM_2019_98154 crossref_primary_10_1007_s00761_020_00734_5 crossref_primary_10_3389_fonc_2024_1353580 crossref_primary_10_1111_jog_15995 crossref_primary_10_3390_v13061113 crossref_primary_10_1016_j_anaerobe_2020_102300 crossref_primary_10_1097_QAI_0000000000003206 crossref_primary_10_2174_2211536608666191026115045 crossref_primary_10_1016_j_eclinm_2020_100401 crossref_primary_10_1136_jitc_2020_001395 crossref_primary_10_3390_ai5040144 crossref_primary_10_3390_cancers15072167 crossref_primary_10_7717_peerj_15570 crossref_primary_10_1128_mmbr_00153_23 crossref_primary_10_1016_j_bpobgyn_2017_08_006 crossref_primary_10_1038_s41416_018_0273_9 crossref_primary_10_3389_fpubh_2022_840879 crossref_primary_10_3390_vaccines8010047 crossref_primary_10_1007_s10096_021_04362_8 crossref_primary_10_3390_bios12050290 crossref_primary_10_1002_jmv_28084 crossref_primary_10_1080_21645515_2023_2225389 crossref_primary_10_1016_j_sapharm_2018_05_013 crossref_primary_10_1111_hiv_13227 crossref_primary_10_1038_s41598_023_35153_0 crossref_primary_10_1016_j_pec_2019_09_017 crossref_primary_10_1002_14651858_CD013479 crossref_primary_10_1186_s12939_019_1090_3 crossref_primary_10_1016_j_coviro_2021_07_010 crossref_primary_10_1093_jnci_djad169 crossref_primary_10_1016_j_arres_2024_100111 crossref_primary_10_1136_sextrans_2022_055447 crossref_primary_10_3390_pathogens10081026 crossref_primary_10_1002_cncr_33795 crossref_primary_10_3201_eid2701_191364 crossref_primary_10_7759_cureus_53447 crossref_primary_10_1016_j_gene_2021_145533 crossref_primary_10_1038_s41598_025_90024_0 crossref_primary_10_1136_jclinpath_2020_206686 crossref_primary_10_38136_jgon_1074012 crossref_primary_10_1530_JME_19_0011 crossref_primary_10_1016_S2352_3018_18_30216_9 crossref_primary_10_1007_s13187_018_1373_1 crossref_primary_10_1371_journal_pgph_0001982 crossref_primary_10_1016_j_jsxm_2020_05_028 crossref_primary_10_3390_tropicalmed10020036 crossref_primary_10_1016_j_celrep_2023_112508 crossref_primary_10_1016_j_ygyno_2020_10_037 crossref_primary_10_1016_j_canlet_2019_10_046 crossref_primary_10_7717_peerj_16247 crossref_primary_10_2147_OTT_S293163 crossref_primary_10_3390_cancers16081584 crossref_primary_10_36384_01232576_430 crossref_primary_10_1002_rmv_2505 crossref_primary_10_1093_advances_nmz013 crossref_primary_10_1080_01635581_2020_1737151 crossref_primary_10_1080_21645515_2024_2308378 crossref_primary_10_2174_1389200221666200421121228 crossref_primary_10_1002_hed_26906 crossref_primary_10_3390_v15071431 crossref_primary_10_1111_idh_12746 crossref_primary_10_1177_03000605251325996 crossref_primary_10_1371_journal_pone_0268104 crossref_primary_10_1016_j_ygeno_2021_09_006 crossref_primary_10_4178_epih_e2023076 crossref_primary_10_3390_biology11081114 crossref_primary_10_1016_j_ijid_2021_06_006 crossref_primary_10_1017_S0950268821001175 crossref_primary_10_29059_cienciauat_v17i2_1756 crossref_primary_10_5306_wjco_v15_i12_1491 crossref_primary_10_1016_j_clinsp_2023_100219 crossref_primary_10_1016_j_tvr_2023_200258 crossref_primary_10_17650_2313_805X_2024_11_3_56_67 crossref_primary_10_3389_fcimb_2022_814948 crossref_primary_10_1002_ijc_32848 crossref_primary_10_1371_journal_pone_0215412 crossref_primary_10_1186_s12889_024_17733_5 crossref_primary_10_1186_s12914_019_0195_5 crossref_primary_10_1016_j_celrep_2022_111546 crossref_primary_10_25207_1608_6228_2022_29_3_103_120 crossref_primary_10_3389_fpubh_2024_1357073 crossref_primary_10_1007_s40944_019_0307_0 crossref_primary_10_1002_hed_28065 crossref_primary_10_4103_singaporemedj_SMJ_2020_446 crossref_primary_10_3389_fimmu_2020_01750 crossref_primary_10_1007_s10147_023_02411_0 crossref_primary_10_1186_s13046_021_01841_w crossref_primary_10_3390_ijms232415512 crossref_primary_10_3390_ijerph18178999 crossref_primary_10_1007_s00761_020_00756_z crossref_primary_10_3390_healthcare12232339 crossref_primary_10_1007_s40944_022_00702_4 crossref_primary_10_1053_j_gastro_2020_10_022 crossref_primary_10_1186_s12978_024_01913_y crossref_primary_10_4044_joma_135_123 crossref_primary_10_1186_s12889_024_20546_1 crossref_primary_10_1016_j_ejca_2021_07_041 crossref_primary_10_1080_21645515_2022_2132755 crossref_primary_10_1002_adtp_202200239 crossref_primary_10_14309_ctg_0000000000000558 crossref_primary_10_1016_j_vaccine_2023_10_024 crossref_primary_10_1038_s41467_024_54373_0 crossref_primary_10_1371_journal_pone_0301212 crossref_primary_10_1096_fj_201801099RR crossref_primary_10_1080_13696998_2024_2384264 crossref_primary_10_1136_sextrans_2022_055484 crossref_primary_10_1186_s12889_024_20490_0 crossref_primary_10_1016_j_canep_2023_102493 crossref_primary_10_1093_jnci_djac034 crossref_primary_10_1016_j_jgo_2022_04_002 crossref_primary_10_1016_j_ijid_2021_06_024 crossref_primary_10_1016_j_critrevonc_2021_103310 crossref_primary_10_12677_ACM_2023_1392010 crossref_primary_10_1007_s42764_023_00109_1 crossref_primary_10_1016_j_lana_2023_100443 crossref_primary_10_1111_eve_13506 crossref_primary_10_1111_cas_15269 crossref_primary_10_1177_03000605241291754 crossref_primary_10_1093_cid_ciz144 crossref_primary_10_1002_14651858_CD013430 crossref_primary_10_1080_1040841X_2021_1944052 crossref_primary_10_1186_s12889_023_15842_1 crossref_primary_10_1016_j_gim_2022_01_006 crossref_primary_10_3389_fphar_2021_674682 crossref_primary_10_1080_15321819_2021_1985515 crossref_primary_10_1128_jvi_01865_21 crossref_primary_10_1371_journal_ppat_1007575 crossref_primary_10_1007_s00262_021_03134_9 crossref_primary_10_1080_21645515_2020_1865739 crossref_primary_10_1093_infdis_jiy556 crossref_primary_10_3390_ijms20215455 crossref_primary_10_1002_ijc_34811 crossref_primary_10_1177_0194599820908596 crossref_primary_10_1097_EDE_0000000000001375 crossref_primary_10_3390_women4010004 crossref_primary_10_1002_ijc_31549 crossref_primary_10_1093_infdis_jiac115 crossref_primary_10_1186_s12916_025_03954_x crossref_primary_10_1016_j_bbamcr_2023_119536 crossref_primary_10_1016_j_pdpdt_2022_102974 crossref_primary_10_1016_j_jiph_2019_08_017 crossref_primary_10_1016_j_pvr_2019_100184 crossref_primary_10_1097_QAI_0000000000003057 crossref_primary_10_3390_v14010024 crossref_primary_10_1007_s12326_021_00453_7 crossref_primary_10_1186_s12885_020_07170_z crossref_primary_10_15570_actaapa_2019_18 crossref_primary_10_3390_pathogens9100786 crossref_primary_10_1038_s41598_022_15088_8 crossref_primary_10_1038_s41419_018_0431_2 crossref_primary_10_1371_journal_pone_0307658 crossref_primary_10_3201_eid2703_202721 crossref_primary_10_1016_j_bios_2023_115968 crossref_primary_10_1016_j_semradonc_2021_03_008 crossref_primary_10_3390_v11100922 crossref_primary_10_3389_fimmu_2024_1445711 crossref_primary_10_1016_j_pedn_2024_02_011 crossref_primary_10_1186_s40001_023_01207_2 crossref_primary_10_1080_13696998_2025_2468120 crossref_primary_10_1016_j_bbcan_2024_189156 crossref_primary_10_1080_13696998_2024_2374684 crossref_primary_10_1002_hsr2_1421 crossref_primary_10_1093_cid_ciz168 crossref_primary_10_4178_epih_e2021013 crossref_primary_10_30629_0023_2149_2024_102_5_6_415_421 crossref_primary_10_3390_vaccines11081354 crossref_primary_10_1016_j_canep_2021_102068 crossref_primary_10_1016_j_canlet_2019_02_024 crossref_primary_10_1002_rmv_2537 crossref_primary_10_1016_j_intimp_2022_108896 crossref_primary_10_1002_cam4_70686 crossref_primary_10_1038_s41598_020_59967_4 crossref_primary_10_1016_j_pvr_2019_100179 crossref_primary_10_1016_j_vaccine_2020_07_030 crossref_primary_10_3390_cancers16183156 crossref_primary_10_1038_s41598_025_94563_4 crossref_primary_10_1007_s10552_021_01493_3 crossref_primary_10_1007_s42058_023_00123_y crossref_primary_10_1093_infdis_jiz422 crossref_primary_10_1093_infdis_jiz425 crossref_primary_10_3889_oamjms_2023_11689 crossref_primary_10_3389_fcimb_2022_1077651 crossref_primary_10_1016_j_canep_2022_102140 crossref_primary_10_1038_s41467_022_28724_8 crossref_primary_10_1038_s41571_024_00904_z crossref_primary_10_1016_j_actpha_2022_11_011 crossref_primary_10_1002_lary_29034 crossref_primary_10_1016_j_archoralbio_2023_105830 crossref_primary_10_1016_j_micpath_2022_105462 crossref_primary_10_1016_j_adaj_2022_09_014 crossref_primary_10_1186_s12879_022_07893_3 crossref_primary_10_1371_journal_pone_0209303 crossref_primary_10_35509_01239015_30 crossref_primary_10_2147_AHMT_S394119 crossref_primary_10_1007_s12094_025_03868_3 crossref_primary_10_1016_j_semcancer_2022_03_007 crossref_primary_10_1089_vim_2017_0119 crossref_primary_10_3390_pathogens14030221 crossref_primary_10_1002_ijc_33513 crossref_primary_10_1080_01443615_2020_1737662 crossref_primary_10_1002_ijc_33514 crossref_primary_10_1016_j_cell_2018_02_045 crossref_primary_10_1097_NCC_0000000000001156 crossref_primary_10_1371_journal_pone_0253074 crossref_primary_10_2478_prolas_2021_0002 crossref_primary_10_1016_j_biopha_2024_117519 crossref_primary_10_1126_scitranslmed_abn4768 crossref_primary_10_1039_D0FO00207K crossref_primary_10_1371_journal_pdig_0000364 crossref_primary_10_1016_j_ejogrb_2024_07_037 crossref_primary_10_1186_s12985_019_1132_x crossref_primary_10_1002_cncr_34006 crossref_primary_10_1007_s00259_023_06320_2 crossref_primary_10_3390_v14050953 crossref_primary_10_1016_j_jpp_2021_02_003 crossref_primary_10_1016_j_pvr_2018_12_002 crossref_primary_10_1136_sextrans_2019_054301 crossref_primary_10_1186_s12985_020_01420_z crossref_primary_10_1016_j_jpag_2018_06_010 crossref_primary_10_1097_JS9_0000000000002117 crossref_primary_10_1016_j_heliyon_2023_e22497 crossref_primary_10_1039_D1CC00756D crossref_primary_10_1016_j_vaccine_2018_10_050 crossref_primary_10_1177_10732748231218088 crossref_primary_10_1093_infdis_jiad005 crossref_primary_10_1186_s12879_020_05632_0 crossref_primary_10_2139_ssrn_4194673 crossref_primary_10_1016_j_pvr_2020_100203 crossref_primary_10_1016_j_pvr_2020_100202 crossref_primary_10_3390_ijms24119543 crossref_primary_10_1016_j_vaccine_2022_08_020 crossref_primary_10_1093_infdis_jiad485 crossref_primary_10_1016_S2468_2667_20_30209_7 crossref_primary_10_15570_actaapa_2022_4 crossref_primary_10_3390_cancers10120521 crossref_primary_10_1016_j_pvr_2020_100205 crossref_primary_10_1016_j_esmoop_2021_100154 crossref_primary_10_1016_j_jmb_2018_04_016 crossref_primary_10_1016_j_canep_2024_102716 crossref_primary_10_21763_tjfmpc_651359 crossref_primary_10_1111_imm_13285 crossref_primary_10_2174_1389201020666190802115722 crossref_primary_10_3390_v14081656 crossref_primary_10_1080_14728214_2024_2339906 crossref_primary_10_1002_hed_27166 crossref_primary_10_1016_j_pvr_2020_100208 crossref_primary_10_1186_s12889_023_15615_w crossref_primary_10_15789_2220_7619_TPO_17690 crossref_primary_10_1016_j_pep_2020_105690 crossref_primary_10_1093_infdis_jiae345 crossref_primary_10_1186_s12889_024_21006_6 crossref_primary_10_1136_bmjsrh_2019_200352 crossref_primary_10_1080_21645515_2022_2082192 crossref_primary_10_1111_scd_13018 crossref_primary_10_1128_mBio_02684_21 crossref_primary_10_3390_jcm12062303 crossref_primary_10_1002_1878_0261_12808 crossref_primary_10_3238_arztebl_2018_0646 crossref_primary_10_1007_s00292_022_01159_0 crossref_primary_10_1016_j_tim_2017_07_007 crossref_primary_10_1136_bmjopen_2021_056502 crossref_primary_10_1111_odi_13221 crossref_primary_10_3389_fpubh_2024_1414631 crossref_primary_10_3390_cimb45070366 crossref_primary_10_3390_v10020080 crossref_primary_10_1136_bmjopen_2022_065749 crossref_primary_10_1186_s13027_024_00601_7 crossref_primary_10_1016_j_omto_2018_05_001 crossref_primary_10_1186_s13027_020_00301_y crossref_primary_10_1002_ijc_31128 crossref_primary_10_1016_j_canlet_2018_09_018 crossref_primary_10_3390_diagnostics11122180 crossref_primary_10_3390_microorganisms9061179 crossref_primary_10_1093_pubmed_fdaa246 crossref_primary_10_1016_j_lanmic_2024_100955 crossref_primary_10_1093_infdis_jiz224 crossref_primary_10_3389_fonc_2024_1480983 crossref_primary_10_1016_j_semradonc_2021_02_011 crossref_primary_10_3389_fcimb_2023_1138232 crossref_primary_10_1038_s41564_022_01177_x crossref_primary_10_1093_infdis_jiy133 crossref_primary_10_1097_PAS_0000000000002312 crossref_primary_10_2147_CMAR_S379173 crossref_primary_10_1186_s12905_022_01930_8 crossref_primary_10_1002_hsr2_70506 crossref_primary_10_3389_fpubh_2022_908302 crossref_primary_10_1016_j_jmoldx_2023_11_007 crossref_primary_10_1002_puh2_126 crossref_primary_10_1097_MS9_0000000000001935 crossref_primary_10_1016_j_jfscie_2024_100031 crossref_primary_10_1016_j_mam_2023_101224 crossref_primary_10_1016_j_heliyon_2025_e42437 crossref_primary_10_3389_fcell_2021_661472 crossref_primary_10_36233_0372_9311_327 crossref_primary_10_3390_biomedicines11123183 crossref_primary_10_1080_21645515_2022_2061248 crossref_primary_10_1016_j_vaccine_2018_02_006 crossref_primary_10_2139_ssrn_4101075 crossref_primary_10_3322_caac_21871 crossref_primary_10_3390_curroncol29050303 crossref_primary_10_1016_j_soncn_2022_151284 crossref_primary_10_3390_cancers14010030 crossref_primary_10_1093_jnci_djaa010 crossref_primary_10_1093_infdis_jiac147 crossref_primary_10_3390_cancers14010033 crossref_primary_10_1038_s41598_020_70118_7 crossref_primary_10_1016_j_heliyon_2024_e34999 crossref_primary_10_3390_cancers15092643 crossref_primary_10_1177_13591053241253065 crossref_primary_10_3390_cancers15010263 crossref_primary_10_2147_OTT_S251926 crossref_primary_10_3390_vaccines11050896 crossref_primary_10_3390_vaccines11081371 crossref_primary_10_1016_j_ygyno_2020_01_030 crossref_primary_10_1371_journal_pone_0297054 crossref_primary_10_1177_10732748241284907 crossref_primary_10_1097_RHU_0000000000002122 crossref_primary_10_1371_journal_pone_0185669 crossref_primary_10_34172_jech_2781 crossref_primary_10_2147_IJGM_S308215 crossref_primary_10_1016_j_gore_2022_101001 crossref_primary_10_1007_s13224_023_01751_1 crossref_primary_10_1186_s12935_018_0595_y crossref_primary_10_1016_S1473_3099_21_00327_3 crossref_primary_10_1080_13696998_2024_2350877 crossref_primary_10_1097_LGT_0000000000000631 crossref_primary_10_1542_peds_2019_4035 crossref_primary_10_1016_j_soncn_2019_02_003 crossref_primary_10_1186_s12889_025_21599_6 crossref_primary_10_3390_vaccines10091560 crossref_primary_10_4236_ojepi_2023_134022 crossref_primary_10_1186_s12894_020_00628_z crossref_primary_10_2147_CMAR_S276629 crossref_primary_10_1002_ijgo_12937 crossref_primary_10_1097_OLQ_0000000000001606 crossref_primary_10_1371_journal_pone_0187615 crossref_primary_10_1371_journal_pone_0291725 crossref_primary_10_1002_jmv_29837 crossref_primary_10_3390_diagnostics15070825 crossref_primary_10_1002_mma_9584 crossref_primary_10_1002_dc_24891 crossref_primary_10_19127_mbsjohs_1256837 crossref_primary_10_1080_21645515_2018_1558688 crossref_primary_10_1002_cpmc_119 crossref_primary_10_1016_j_trsl_2022_05_002 crossref_primary_10_1099_acmi_0_000216 crossref_primary_10_1155_2022_7342061 crossref_primary_10_29413_ABS_2024_9_2_12 crossref_primary_10_1128_mBio_00152_19 crossref_primary_10_1038_s41598_018_33243_y crossref_primary_10_1080_17482631_2023_2295879 crossref_primary_10_1111_jop_13172 crossref_primary_10_1016_j_vaccine_2022_05_025 crossref_primary_10_3390_v16020193 crossref_primary_10_5812_archcid_121143 crossref_primary_10_1016_j_mehy_2020_109979 crossref_primary_10_1099_jgv_0_001438 crossref_primary_10_1158_1078_0432_CCR_19_3211 crossref_primary_10_3389_fpubh_2022_891991 crossref_primary_10_1016_j_oraloncology_2024_107171 crossref_primary_10_1158_1055_9965_EPI_23_0547 crossref_primary_10_1186_s13662_024_03823_6 crossref_primary_10_1016_j_ebiom_2020_102857 crossref_primary_10_1002_jmv_28761 crossref_primary_10_30841_2708_8731_4_2024_308991 crossref_primary_10_1097_LGT_0000000000000652 crossref_primary_10_3390_vaccines10122025 crossref_primary_10_1002_ijc_32255 crossref_primary_10_58240_1829006X_2023_19_2_124 crossref_primary_10_1016_j_vaccine_2022_06_030 crossref_primary_10_1186_s13033_021_00477_9 crossref_primary_10_1038_s41571_021_00514_z crossref_primary_10_1089_vim_2019_0094 crossref_primary_10_1097_LGT_0000000000000416 crossref_primary_10_2174_1568026623666230825094341 crossref_primary_10_3892_or_2021_8196 crossref_primary_10_1080_10410236_2023_2287276 crossref_primary_10_1007_s10552_024_01920_1 crossref_primary_10_1016_j_oraloncology_2025_107208 crossref_primary_10_1002_ijc_32491 crossref_primary_10_1016_j_jinf_2022_04_038 crossref_primary_10_1016_j_tranon_2024_101884 crossref_primary_10_1080_21645515_2022_2161253 crossref_primary_10_1093_cid_ciaa002 crossref_primary_10_1016_j_vaccine_2022_05_019 crossref_primary_10_1080_13696998_2023_2282912 crossref_primary_10_1093_annonc_mdz138 crossref_primary_10_1038_s41598_023_49197_9 crossref_primary_10_1002_cam4_2697 crossref_primary_10_7717_peerj_18158 crossref_primary_10_3390_pathogens12030416 crossref_primary_10_3390_v15091857 crossref_primary_10_1016_j_vaccine_2024_01_105 crossref_primary_10_1128_JVI_01930_20 crossref_primary_10_1186_s13027_019_0250_9 crossref_primary_10_1186_s12916_024_03686_4 crossref_primary_10_31631_2073_3046_2020_19_2_110_118 crossref_primary_10_3322_caac_21820 crossref_primary_10_3389_fimmu_2020_586796 crossref_primary_10_1007_s00253_021_11713_0 crossref_primary_10_1097_OLQ_0000000000001875 crossref_primary_10_1038_s41598_024_69439_8 crossref_primary_10_1056_NEJMcp2108502 crossref_primary_10_1007_s10552_023_01729_4 crossref_primary_10_2196_30340 crossref_primary_10_3389_fcimb_2020_537650 crossref_primary_10_1038_s41598_022_17318_5 crossref_primary_10_3802_jgo_2022_33_e4 crossref_primary_10_1016_j_jiph_2020_05_024 crossref_primary_10_3390_ijms24043482 crossref_primary_10_3390_biomedicines11030791 crossref_primary_10_3389_fpubh_2022_1003461 crossref_primary_10_1016_j_jmoldx_2021_07_005 crossref_primary_10_1093_heapro_daz030 crossref_primary_10_1002_jmv_29875 crossref_primary_10_1080_21645515_2022_2073750 crossref_primary_10_1002_mc_23656 crossref_primary_10_1097_OLQ_0000000000001802 crossref_primary_10_1002_iid3_1111 crossref_primary_10_1080_14760584_2017_1383158 crossref_primary_10_1128_jvi_01024_24 crossref_primary_10_1158_1055_9965_EPI_21_1373 crossref_primary_10_3389_fgwh_2023_1187916 crossref_primary_10_3390_jcm11041101 crossref_primary_10_1038_s41443_024_00889_4 crossref_primary_10_1055_s_0041_1736643 crossref_primary_10_17116_profmed20212402130 crossref_primary_10_1007_s10935_020_00598_w crossref_primary_10_1177_09564624221076293 crossref_primary_10_3390_genes13040594 crossref_primary_10_1016_j_measen_2023_100782 crossref_primary_10_3389_fmed_2023_1301440 crossref_primary_10_1016_j_vaccine_2020_02_009 crossref_primary_10_3389_fpubh_2022_820517 crossref_primary_10_1016_j_antiviral_2023_105667 crossref_primary_10_1016_j_cct_2021_106592 crossref_primary_10_1371_journal_pgen_1009254 crossref_primary_10_1038_s41379_022_01020_y crossref_primary_10_1038_s41598_019_46077_z crossref_primary_10_1002_jcb_29008 crossref_primary_10_1007_s00432_023_05399_2 crossref_primary_10_1007_s13187_019_01582_7 crossref_primary_10_1097_LGT_0000000000000687 crossref_primary_10_1136_ijgc_2023_004743 crossref_primary_10_1007_s10147_023_02340_y crossref_primary_10_1016_j_ypmed_2018_08_034 crossref_primary_10_1128_MRA_00630_21 crossref_primary_10_1177_11779322241304666 crossref_primary_10_23736_S1824_4785_19_03156_X crossref_primary_10_1136_jitc_2022_005752 crossref_primary_10_1093_oncolo_oyac144 crossref_primary_10_3389_fpubh_2022_799984 crossref_primary_10_12677_ACM_2018_86091 crossref_primary_10_18597_rcog_3646 crossref_primary_10_3390_v16091357 crossref_primary_10_1111_febs_16718 crossref_primary_10_1016_j_eururo_2022_03_001 crossref_primary_10_2174_1381612826666200114100553 crossref_primary_10_3389_fimmu_2022_863164 crossref_primary_10_1016_j_cellsig_2020_109815 crossref_primary_10_1111_imcb_12650 crossref_primary_10_3390_v9070174 crossref_primary_10_1007_s10103_021_03326_w crossref_primary_10_3390_cancers14112607 crossref_primary_10_1093_cid_ciaa1770 crossref_primary_10_1128_jvi_01498_22 crossref_primary_10_3389_fimmu_2024_1334829 crossref_primary_10_1080_21645515_2021_1882283 crossref_primary_10_1158_1078_0432_CCR_21_0625 crossref_primary_10_1093_jnci_djy225 crossref_primary_10_1158_1940_6207_CAPR_20_0096 crossref_primary_10_3390_cancers17030344 crossref_primary_10_1177_0956462418755882 crossref_primary_10_1073_pnas_2307721120 crossref_primary_10_1007_s10654_018_0365_0 crossref_primary_10_1016_j_nurpra_2023_104711 crossref_primary_10_1038_s41388_019_0741_6 crossref_primary_10_3390_v9070180 crossref_primary_10_1016_S2352_4642_20_30038_9 crossref_primary_10_1097_OLQ_0000000000000979 crossref_primary_10_1002_hed_26330 crossref_primary_10_1093_ofid_ofac595 crossref_primary_10_1177_2399202618799691 crossref_primary_10_1016_j_ejca_2023_112981 crossref_primary_10_1016_j_pedn_2022_08_011 crossref_primary_10_1007_s13187_023_02281_0 crossref_primary_10_5858_arpa_2021_0021_OA crossref_primary_10_1007_s00345_020_03510_7 crossref_primary_10_3390_md17110615 crossref_primary_10_1158_1055_9965_EPI_21_1124 crossref_primary_10_3802_jgo_2018_29_e14 crossref_primary_10_1016_j_jvacx_2024_100557 crossref_primary_10_1371_journal_pone_0244722 crossref_primary_10_1055_s_0043_1774295 crossref_primary_10_1089_apc_2023_0231 crossref_primary_10_1097_OLQ_0000000000001830 crossref_primary_10_1111_coa_12938 crossref_primary_10_1186_s13027_024_00619_x crossref_primary_10_1136_bmjopen_2017_020343 crossref_primary_10_1016_S2468_1253_20_30304_6 crossref_primary_10_1051_bmdcn_2018080318 crossref_primary_10_4103_jomfp_JOMFP_97_17 crossref_primary_10_1177_25151355241308313 crossref_primary_10_1016_j_lanwpc_2021_100196 crossref_primary_10_1002_ijc_34250 crossref_primary_10_3802_jgo_2020_31_e4 crossref_primary_10_31631_2073_3046_2018_17_5_100_105 crossref_primary_10_1002_cncr_32412 crossref_primary_10_1093_molbev_msx305 crossref_primary_10_1186_s12967_023_04676_5 crossref_primary_10_3390_vaccines13020130 crossref_primary_10_1002_cnr2_70116 crossref_primary_10_1007_s10151_019_02019_5 crossref_primary_10_1158_1055_9965_EPI_20_0749 crossref_primary_10_1148_rg_230179 crossref_primary_10_1080_14760584_2023_2162505 crossref_primary_10_1172_jci_insight_141912 crossref_primary_10_1038_s41598_019_51679_8 crossref_primary_10_1186_s13027_025_00636_4 crossref_primary_10_1186_s12889_023_15896_1 crossref_primary_10_3389_fpubh_2024_1455931 crossref_primary_10_3390_cancers12051246 crossref_primary_10_3390_ijms24097698 crossref_primary_10_1007_s10096_024_04963_z crossref_primary_10_1039_C9NJ03241J crossref_primary_10_17650_1726_9784_2019_19_1_6_12 crossref_primary_10_1186_s12879_020_05627_x crossref_primary_10_1016_j_prp_2024_155642 crossref_primary_10_1093_cid_ciz606 crossref_primary_10_15789_2220_7619_DOH_1981 crossref_primary_10_1016_j_annonc_2021_06_015 crossref_primary_10_1080_14760584_2022_2129615 crossref_primary_10_1002_jso_25320 crossref_primary_10_3390_ijms252413643 crossref_primary_10_1007_s11262_024_02089_0 crossref_primary_10_1007_s13187_019_01512_7 crossref_primary_10_33417_tsh_1052993 crossref_primary_10_1093_infdis_jiaa621 crossref_primary_10_1002_advs_202202437 crossref_primary_10_2139_ssrn_4003138 crossref_primary_10_1186_s12885_022_10010_x crossref_primary_10_1111_ajt_15292 crossref_primary_10_3390_vaccines12101110 crossref_primary_10_1002_pbc_29962 crossref_primary_10_3390_pathogens10111411 crossref_primary_10_1080_21645515_2023_2281700 crossref_primary_10_1097_OLQ_0000000000001455 crossref_primary_10_1007_s12254_019_00551_6 crossref_primary_10_1111_odi_14196 crossref_primary_10_1016_j_vaccine_2018_06_046 crossref_primary_10_1186_s12875_021_01612_8 crossref_primary_10_4236_jibtva_2024_132002 crossref_primary_10_31631_2073_3046_2020_20_2_110_118 crossref_primary_10_3389_fviro_2023_1103737 crossref_primary_10_3390_ijms23095050 crossref_primary_10_1007_s10943_023_01886_5 crossref_primary_10_1186_s12985_024_02292_3 crossref_primary_10_1016_j_antiviral_2019_104559 crossref_primary_10_1016_j_ram_2020_06_004 crossref_primary_10_7759_cureus_43483 crossref_primary_10_1002_14651858_CD015363 crossref_primary_10_1016_j_eclinm_2025_103127 crossref_primary_10_1002_14651858_CD015364 crossref_primary_10_1177_11782234211002499 crossref_primary_10_3389_fonc_2022_977933 crossref_primary_10_3390_ijerph18168500 crossref_primary_10_1093_infdis_jiae190 crossref_primary_10_3390_ijms25063437 crossref_primary_10_3390_vaccines11061071 crossref_primary_10_1016_S1470_2045_23_00013_X crossref_primary_10_3389_fonc_2022_848628 crossref_primary_10_1002_jmv_25899 crossref_primary_10_1186_s13063_024_08366_5 crossref_primary_10_1016_j_ejso_2020_12_011 crossref_primary_10_18632_oncotarget_22463 crossref_primary_10_1002_jmv_27837 crossref_primary_10_3390_diseases13010018 crossref_primary_10_3390_pathogens13080653 crossref_primary_10_3390_cancers12113101 crossref_primary_10_1080_21645515_2023_2258569 crossref_primary_10_6061_clinics_2018_e627s crossref_primary_10_1016_j_radonc_2022_01_017 crossref_primary_10_1371_journal_pone_0249134 crossref_primary_10_1016_j_gore_2024_101445 crossref_primary_10_1016_j_tranon_2025_102363 crossref_primary_10_1038_s41585_025_00994_z crossref_primary_10_3390_vaccines11061060 crossref_primary_10_3390_v16050667 crossref_primary_10_1016_j_ygyno_2019_10_018 crossref_primary_10_1073_pnas_1801156115 crossref_primary_10_1371_journal_pbio_3002949 crossref_primary_10_1016_j_lanwpc_2023_100793 crossref_primary_10_1080_21645515_2021_1885967 crossref_primary_10_1007_s11033_024_10017_6 crossref_primary_10_1002_jmv_25666 crossref_primary_10_1111_jdv_19839 crossref_primary_10_1002_hsr2_2149 crossref_primary_10_1002_iju5_12664 crossref_primary_10_2147_CMAR_S262678 crossref_primary_10_3390_v16030416 crossref_primary_10_1016_j_ypmed_2024_108165 crossref_primary_10_1111_ctr_14476 crossref_primary_10_1371_journal_pone_0226261 crossref_primary_10_3390_cells9061359 crossref_primary_10_1016_j_canep_2025_102799 crossref_primary_10_1016_j_jfranklin_2023_06_008 crossref_primary_10_3892_ijo_2019_4847 crossref_primary_10_1016_j_jvacx_2022_100141 crossref_primary_10_1097_QAD_0000000000003995 crossref_primary_10_3390_ijms22179143 crossref_primary_10_3390_vaccines11010102 crossref_primary_10_1016_j_virol_2024_110211 crossref_primary_10_1016_j_ad_2024_05_026 crossref_primary_10_1016_j_vaccine_2018_08_071 crossref_primary_10_3390_v16050679 crossref_primary_10_3390_vaccines11061084 crossref_primary_10_1186_s12905_024_03377_5 crossref_primary_10_1007_s40618_023_02192_3 crossref_primary_10_1016_j_ypmed_2021_106554 crossref_primary_10_1097_OLQ_0000000000001407 crossref_primary_10_2105_AJPH_2020_305827 crossref_primary_10_3390_biomedicines9060683 crossref_primary_10_1093_jnci_djad189 crossref_primary_10_1186_s12985_023_02073_4 crossref_primary_10_1016_j_vaccine_2024_126644 crossref_primary_10_1111_pde_14740 crossref_primary_10_3390_v14092054 crossref_primary_10_1002_jmv_70002 crossref_primary_10_1007_s00784_023_04926_2 crossref_primary_10_1093_jnci_djad187 crossref_primary_10_1016_j_ejca_2019_02_012 crossref_primary_10_3390_life13081775 crossref_primary_10_3390_cancers15164080 crossref_primary_10_3389_fgene_2022_875939 crossref_primary_10_1016_j_eclinm_2024_103018 crossref_primary_10_1016_j_tranon_2018_02_017 crossref_primary_10_1038_s41598_022_06922_0 crossref_primary_10_3390_cancers14215257 crossref_primary_10_1111_ddg_15294_g crossref_primary_10_1186_s12879_022_07130_x crossref_primary_10_5937_mp73_35462 crossref_primary_10_3390_cancers13164083 crossref_primary_10_1093_milmed_usy376 crossref_primary_10_3390_vaccines7040200 crossref_primary_10_1128_mbio_02302_22 crossref_primary_10_1016_S1773_035X_22_00100_9 crossref_primary_10_1080_00325481_2021_1904669 crossref_primary_10_1016_j_vaccine_2018_07_018 crossref_primary_10_3390_vaccines10091515 crossref_primary_10_1038_s41467_024_50588_3 crossref_primary_10_1002_path_5387 crossref_primary_10_1007_s00705_021_05259_9 crossref_primary_10_1016_j_xphs_2023_02_007 crossref_primary_10_1093_heapro_daab056 crossref_primary_10_1371_journal_pone_0228660 crossref_primary_10_1016_j_canep_2020_101682 crossref_primary_10_52538_iduhes_1021327 crossref_primary_10_1080_14737167_2025_2451732 crossref_primary_10_1158_1535_7163_MCT_19_0625 crossref_primary_10_1071_SH24250 crossref_primary_10_22627_2072_8107_2025_24_1_37_42 crossref_primary_10_1016_j_jadohealth_2025_01_011 crossref_primary_10_1186_s12985_024_02413_y crossref_primary_10_1016_j_jpag_2024_02_001 crossref_primary_10_1016_j_revssu_2021_02_005 crossref_primary_10_1016_j_vaccine_2019_01_069 crossref_primary_10_5858_arpa_2019_0199_OA crossref_primary_10_3390_cancers15051452 crossref_primary_10_1038_s41467_022_33544_x crossref_primary_10_1093_jncimonographs_lgae026 crossref_primary_10_1371_journal_pone_0192621 crossref_primary_10_3389_fcell_2024_1388423 crossref_primary_10_1186_s12859_020_3454_5 crossref_primary_10_1007_s10989_019_09985_2 crossref_primary_10_1038_s41419_024_06867_4 crossref_primary_10_3390_v13101892 crossref_primary_10_1007_s00761_018_0516_7 crossref_primary_10_2139_ssrn_3960671 crossref_primary_10_1097_QAD_0000000000002694 crossref_primary_10_1080_21645515_2022_2126251 crossref_primary_10_3389_fonc_2022_864066 crossref_primary_10_1080_13696998_2024_2368986
Cites_doi	10.1097/QAD.0000000000000808 10.1093/jnci/djv403 10.3201/eid2201.150736 10.1016/j.ijgo.2015.07.038 10.1016/j.vaccine.2016.02.067 10.1038/nrclinonc.2013.84 10.1002/ijc.27485 10.1016/S0140-6736(13)60022-7 10.1038/nrclinonc.2015.146 10.1200/JCO.2011.36.4596 10.1016/j.ejca.2015.06.001 10.1016/S1470-2045(10)70017-6 10.1016/j.eururo.2015.12.007 10.1038/nature21386 10.1016/S1470-2045(15)00047-9 10.1097/QAI.0000000000001113 10.1016/S2214-109X(16)30099-7 10.1111/jop.12123 10.1016/S2214-109X(14)70237-2 10.1016/S2214-109X(16)30143-7 10.1093/jnci/djv302
ContentType	Journal Article
Copyright	2017 International Agency for Research on Cancer (IARC/WHO); licensed by UICC 2017 International Agency for Research on Cancer (IARC/WHO); licensed by UICC. 2017 UICC
Copyright_xml	– notice: 2017 International Agency for Research on Cancer (IARC/WHO); licensed by UICC – notice: 2017 International Agency for Research on Cancer (IARC/WHO); licensed by UICC. – notice: 2017 UICC
DBID	24P AAYXX CITATION CGR CUY CVF ECM EIF NPM 7T5 7TO 7U9 H94 K9. 7X8 5PM
DOI	10.1002/ijc.30716
DatabaseName	Wiley Online Library Open Access CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed Immunology Abstracts Oncogenes and Growth Factors Abstracts Virology and AIDS Abstracts AIDS and Cancer Research Abstracts ProQuest Health & Medical Complete (Alumni) MEDLINE - Academic PubMed Central (Full Participant titles)
DatabaseTitle	CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) AIDS and Cancer Research Abstracts ProQuest Health & Medical Complete (Alumni) Immunology Abstracts Virology and AIDS Abstracts Oncogenes and Growth Factors Abstracts MEDLINE - Academic
DatabaseTitleList	CrossRef AIDS and Cancer Research Abstracts MEDLINE MEDLINE - Academic
Database_xml	– sequence: 1 dbid: 24P name: Wiley Online Library Open Access url: https://authorservices.wiley.com/open-science/open-access/browse-journals.html sourceTypes: Publisher – sequence: 2 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 3 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database
DeliveryMethod	fulltext_linktorsrc
Discipline	Medicine
DocumentTitleAlternate	Worldwide burden of cancer attributable to HPV
EISSN	1097-0215
EndPage	670
ExternalDocumentID	PMC5520228 28369882 10_1002_ijc_30716 IJC30716
Genre	article Research Support, Non-U.S. Gov't Journal Article
GrantInformation_xml	– fundername: Bill & Melinda Gates Foundation funderid: OPP1053353 – fundername: Fondation de France funderid: 00039621 – fundername: World Health Organization grantid: 001 – fundername: Fondation de France grantid: 00039621 – fundername: Bill & Melinda Gates Foundation grantid: OPP1053353
GroupedDBID	--- -~X .3N .GA 05W 0R~ 10A 1L6 1OB 1OC 1ZS 24P 33P 3SF 3WU 4.4 4ZD 50Y 50Z 51W 51X 52M 52N 52O 52P 52R 52S 52T 52U 52V 52W 52X 5GY 5VS 66C 702 7PT 8-0 8-1 8-3 8-4 8-5 8UM 930 A01 A03 AAESR AAEVG AAHHS AAHQN AAIPD AAMNL AANLZ AAONW AASGY AAXRX AAYCA AAZKR ABCQN ABCUV ABIJN ABJNI ABLJU ABOCM ABPVW ABQWH ABXGK ACAHQ ACCFJ ACCZN ACFBH ACGFO ACGFS ACGOF ACIWK ACMXC ACPOU ACPRK ACXBN ACXQS ADBBV ADBTR ADEOM ADIZJ ADKYN ADMGS ADOZA ADXAS ADZMN ADZOD AEEZP AEGXH AEIGN AEIMD AENEX AEQDE AEUQT AEUYR AFBPY AFFPM AFGKR AFPWT AFRAH AFWVQ AFZJQ AHBTC AHMBA AIACR AIAGR AITYG AIURR AIWBW AJBDE ALAGY ALMA_UNASSIGNED_HOLDINGS ALUQN ALVPJ AMBMR AMYDB ATUGU AZBYB AZVAB BAFTC BFHJK BHBCM BMXJE BROTX BRXPI BY8 C45 CS3 D-6 D-7 D-E D-F DCZOG DPXWK DR2 DRFUL DRMAN DRSTM DU5 EBS EJD EMOBN F00 F01 F04 F5P FUBAC G-S G.N GNP GODZA H.X HBH HGLYW HHY HHZ HZ~ IH2 IX1 J0M JPC KBYEO KQQ L7B LATKE LAW LC2 LC3 LEEKS LH4 LITHE LOXES LP6 LP7 LUTES LW6 LYRES MEWTI MK4 MRFUL MRMAN MRSTM MSFUL MSMAN MSSTM MXFUL MXMAN MXSTM N04 N05 N9A NF~ NNB O66 O9- OIG OK1 OVD P2P P2W P2X P2Z P4B P4D PQQKQ Q.N Q11 QB0 QRW R.K RIWAO ROL RWI RX1 RYL SUPJJ TEORI UB1 UDS V2E V8K V9Y W2D W8V W99 WBKPD WHWMO WIB WIH WIJ WIK WIN WJL WOHZO WQJ WRC WUP WVDHM WWO WXI WXSBR XG1 XPP XV2 ZZTAW ~IA ~WT AAYXX AEYWJ AGHNM AGYGG CITATION AAMMB AEFGJ AGXDD AIDQK AIDYY CGR CUY CVF ECM EIF NPM 7T5 7TO 7U9 H94 K9. 7X8 5PM
ID	FETCH-LOGICAL-c5096-2535c4dae0360107739b4a3d5c024e20f14d5efb9e4bc9967f7758bda14909583
IEDL.DBID	DR2
ISSN	0020-7136 1097-0215
IngestDate	Thu Aug 21 18:22:09 EDT 2025 Fri Jul 11 15:48:23 EDT 2025 Fri Jul 25 20:00:22 EDT 2025 Mon Jul 21 06:02:42 EDT 2025 Tue Jul 01 02:28:20 EDT 2025 Thu Apr 24 23:10:43 EDT 2025 Wed Jan 22 16:25:13 EST 2025
IsDoiOpenAccess	true
IsOpenAccess	true
IsPeerReviewed	true
IsScholarly	true
Issue	4
Keywords	attributable fraction vaccine cancer prevention human papillomavirus
Language	English
License	Attribution https://creativecommons.org/licenses/by-nc/3.0/igo/legalcode 2017 International Agency for Research on Cancer (IARC/WHO); licensed by UICC. This is an open access article distributed under the terms of the Creative Commons Attribution IGO License IARC's preferred IGO license is the non‐commercial: https://creativecommons.org/licenses/by-nc/3.0/igo/legalcode which permits non‐commercial unrestricted use, distribution and reproduction in any medium, provided that the original work is properly cited. In any reproduction of this article there should not be any suggestion that IARC/WHO or the article endorse any specific organization or products. The use of the IARC/WHO logo is not permitted. This notice should be preserved along with the article's URL.
LinkModel	DirectLink
MergedId	FETCHMERGED-LOGICAL-c5096-2535c4dae0360107739b4a3d5c024e20f14d5efb9e4bc9967f7758bda14909583
Notes	We declare that we have no conflicts of interest. ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 14 content type line 23
ORCID	0000-0002-3642-277X
OpenAccessLink	https://proxy.k.utb.cz/login?url=https://onlinelibrary.wiley.com/doi/abs/10.1002%2Fijc.30716
PMID	28369882
PQID	1910720636
PQPubID	105430
PageCount	7
ParticipantIDs	pubmedcentral_primary_oai_pubmedcentral_nih_gov_5520228 proquest_miscellaneous_1884166116 proquest_journals_1910720636 pubmed_primary_28369882 crossref_primary_10_1002_ijc_30716 crossref_citationtrail_10_1002_ijc_30716 wiley_primary_10_1002_ijc_30716_IJC30716
ProviderPackageCode	CITATION AAYXX
PublicationCentury	2000
PublicationDate	15 August 2017
PublicationDateYYYYMMDD	2017-08-15
PublicationDate_xml	– month: 08 year: 2017 text: 15 August 2017 day: 15
PublicationDecade	2010
PublicationPlace	United States
PublicationPlace_xml	– name: United States – name: Hoboken
PublicationTitle	International journal of cancer
PublicationTitleAlternate	Int J Cancer
PublicationYear	2017
Publisher	Wiley Subscription Services, Inc John Wiley and Sons Inc
Publisher_xml	– name: Wiley Subscription Services, Inc – name: John Wiley and Sons Inc
References	2016; 4 1995; 64 2010; 11 2012; 131 2015; 16 2014; 2 2015; 29 2013; 10 2016; 108 2015; 51 2012; 100B 2007; 90 2016; 132 2017 2016; 73 2013; 382 2013 2011; 29 2016; 69 2016; 13 2014; 43 2016; 34 2016; 22 e_1_2_7_4_1 e_1_2_7_3_1 e_1_2_7_9_1 e_1_2_7_8_1 e_1_2_7_19_1 e_1_2_7_18_1 e_1_2_7_17_1 e_1_2_7_16_1 e_1_2_7_2_1 e_1_2_7_15_1 e_1_2_7_14_1 e_1_2_7_13_1 e_1_2_7_12_1 e_1_2_7_11_1 e_1_2_7_10_1 e_1_2_7_26_1 e_1_2_7_27_1 e_1_2_7_28_1 IARC (e_1_2_7_5_1) 1995; 64 e_1_2_7_25_1 e_1_2_7_24_1 e_1_2_7_23_1 e_1_2_7_22_1 e_1_2_7_21_1 e_1_2_7_20_1 IARC (e_1_2_7_6_1) 2007; 90 IARC (e_1_2_7_7_1) 2012; 100
References_xml	– volume: 131 start-page: 2349 year: 2012 end-page: 59 article-title: Human papillomavirus types in 115,789 HPV‐positive women: a meta‐analysis from cervical infection to cancer publication-title: Int J Cancer – volume: 16 start-page: 775 year: 2015 end-page: 86 article-title: Efficacy of fewer than three doses of an HPV‐16/18 AS04‐adjuvanted vaccine: combined analysis of data from the Costa Rica Vaccine and PATRICIA Trials publication-title: Lancet Oncol – volume: 2 start-page: e406 year: 2014 end-page: 14 article-title: Cost‐effectiveness of female human papillomavirus vaccination in 179 countries: a PRIME modelling study publication-title: Lancet Glob Health – volume: 10 start-page: 400 year: 2013 end-page: 10 article-title: Clinical trials of human papillomavirus vaccines and beyond publication-title: Nat Rev Clin Oncol – year: 2017 article-title: Integrated genomic and molecular characterization of cervical cancer publication-title: Nature – volume: 29 start-page: 4294 year: 2011 end-page: 301 article-title: Human papillomavirus and rising oropharyngeal cancer incidence in the United States publication-title: J Clin Oncol – volume: 4 start-page: e609 year: 2016 end-page: 16 article-title: Global burden of cancers attributable to infections in 2012: a synthetic analysis publication-title: Lancet Glob Health – volume: 11 start-page: 781 year: 2010 end-page: 9 article-title: HPV‐associated head and neck cancer: a virus‐related cancer epidemic publication-title: Lancet Oncol – volume: 132 start-page: 252 year: 2016 end-page: 8 article-title: World Health Organization Guidelines for treatment of cervical intraepithelial neoplasia 2‐3 and screen‐and‐treat strategies to prevent cervical cancer publication-title: Int J Gynaecol Obstet – volume: 43 start-page: 137 year: 2014 end-page: 42 article-title: No evidence for active human papillomavirus (HPV) in fields surrounding HPV‐positive oropharyngeal tumors publication-title: J Oral Pathol Med – volume: 100B start-page: 1 year: 2012 end-page: 475 article-title: Biological Agents publication-title: IARC Monogr Eval Carcinog Risks Hum – volume: 13 start-page: 119 year: 2016 end-page: 32 article-title: HPV‐FASTER: broadening the scope for prevention of HPV‐related cancer publication-title: Nat Rev Clin Oncol – volume: 73 start-page: 332 year: 2016 end-page: 9 article-title: Effect of HIV infection on human papillomavirus types causing invasive cervical cancer in Africa publication-title: J Acquir Immune Defic Syndr – volume: 34 start-page: 3562 year: 2016 end-page: 7 article-title: Quality vaccines for all people: Report on the 16th annual general meeting of the Developing Countries Vaccine Manufacturers' Network, 05‐07th October 2015, Bangkok, Thailand publication-title: Vaccine – volume: 69 start-page: 953 year: 2016 end-page: 61 article-title: Role of Human Papillomavirus in Penile Carcinomas Worldwide publication-title: Eur Urol – volume: 51 start-page: 1732 year: 2015 end-page: 41 article-title: Human papillomavirus genotype attribution for HPVs 6, 11, 16, 18, 31, 33, 45, 52 and 58 in female anogenital lesions publication-title: Eur J Cancer – volume: 29 start-page: 2173 year: 2015 end-page: 81 article-title: Cancers attributable to infections among adults with HIV in the United States publication-title: AIDS – volume: 22 start-page: 56 year: 2016 end-page: 64 article-title: Human Papillomavirus Prevalence and Herd Immunity after Introduction of Vaccination Program, Scotland, 2009‐2013 publication-title: Emerg Infect Dis – volume: 382 start-page: 889 year: 2013 end-page: 99 article-title: Human papillomavirus and cervical cancer publication-title: Lancet – volume: 64 start-page: 1 year: 1995 end-page: 378 article-title: Human papillomaviruses publication-title: IARC Monogr Eval Carcinog Risks Hum – volume: 90 start-page: 1 year: 2007 end-page: 670 article-title: Human Papillomaviruses publication-title: IARC Monogr Eval Carcinog Risks Hum – volume: 108 year: 2016 article-title: Multisite HPV16/18 vaccine efficacy against cervical, anal, and oral hpv infection publication-title: J Natl Cancer Inst – volume: 108 start-page: djv403 year: 2016 article-title: HPV involvement in head and neck cancers: comprehensive assessment of biomarkers in 3680 patients publication-title: J Natl Cancer Inst – volume: 4 start-page: e453 year: 2016 end-page: 63 article-title: Global estimates of human papillomavirus vaccination coverage by region and income level: a pooled analysis publication-title: Lancet Glob Health – year: 2013 – ident: e_1_2_7_21_1 doi: 10.1097/QAD.0000000000000808 – ident: e_1_2_7_14_1 doi: 10.1093/jnci/djv403 – ident: e_1_2_7_26_1 doi: 10.3201/eid2201.150736 – ident: e_1_2_7_4_1 doi: 10.1016/j.ijgo.2015.07.038 – ident: e_1_2_7_28_1 doi: 10.1016/j.vaccine.2016.02.067 – volume: 90 start-page: 1 year: 2007 ident: e_1_2_7_6_1 article-title: Human Papillomaviruses publication-title: IARC Monogr Eval Carcinog Risks Hum – ident: e_1_2_7_24_1 doi: 10.1038/nrclinonc.2013.84 – ident: e_1_2_7_23_1 doi: 10.1002/ijc.27485 – ident: e_1_2_7_16_1 doi: 10.1016/S0140-6736(13)60022-7 – ident: e_1_2_7_22_1 doi: 10.1038/nrclinonc.2015.146 – ident: e_1_2_7_11_1 – ident: e_1_2_7_19_1 doi: 10.1200/JCO.2011.36.4596 – ident: e_1_2_7_15_1 doi: 10.1016/j.ejca.2015.06.001 – ident: e_1_2_7_17_1 doi: 10.1016/S1470-2045(10)70017-6 – volume: 100 start-page: 1 year: 2012 ident: e_1_2_7_7_1 article-title: Biological Agents publication-title: IARC Monogr Eval Carcinog Risks Hum – ident: e_1_2_7_13_1 doi: 10.1016/j.eururo.2015.12.007 – ident: e_1_2_7_20_1 doi: 10.1038/nature21386 – ident: e_1_2_7_25_1 doi: 10.1016/S1470-2045(15)00047-9 – ident: e_1_2_7_10_1 – ident: e_1_2_7_27_1 doi: 10.1097/QAI.0000000000001113 – ident: e_1_2_7_3_1 doi: 10.1016/S2214-109X(16)30099-7 – ident: e_1_2_7_18_1 doi: 10.1111/jop.12123 – volume: 64 start-page: 1 year: 1995 ident: e_1_2_7_5_1 article-title: Human papillomaviruses publication-title: IARC Monogr Eval Carcinog Risks Hum – ident: e_1_2_7_2_1 doi: 10.1016/S2214-109X(14)70237-2 – ident: e_1_2_7_9_1 doi: 10.1016/S2214-109X(16)30143-7 – ident: e_1_2_7_12_1 – ident: e_1_2_7_8_1 doi: 10.1093/jnci/djv302
SSID	ssj0011504
Score	2.6962261
Snippet	HPV is the cause of almost all cervical cancer and is responsible for a substantial fraction of other anogenital cancers and oropharyngeal cancers....
SourceID	pubmedcentral proquest pubmed crossref wiley
SourceType	Open Access Repository Aggregation Database Index Database Enrichment Source Publisher
StartPage	664
SubjectTerms	Africa South of the Sahara - epidemiology Age Anogenital Anus Anus Neoplasms - virology attributable fraction Australia - epidemiology Cancer Cancer Epidemiology Cervical cancer Cross-protection Developing countries Female Head & neck cancer Human papillomavirus Human papillomavirus 16 - isolation & purification Human papillomavirus 18 - isolation & purification Humans Immunization India - epidemiology Infections LDCs Male Medical research Medical screening Neck New Zealand - epidemiology Oropharyngeal Neoplasms - virology Papillomavirus Infections - epidemiology Papillomavirus Infections - virology Penile Neoplasms - virology Penis Prevalence prevention Sex Characteristics Throat cancer United States - epidemiology Uterine Cervical Neoplasms - virology vaccine Vaccines Vagina Vulva
Title	Worldwide burden of cancer attributable to HPV by site, country and HPV type
URI	https://onlinelibrary.wiley.com/doi/abs/10.1002%2Fijc.30716 https://www.ncbi.nlm.nih.gov/pubmed/28369882 https://www.proquest.com/docview/1910720636 https://www.proquest.com/docview/1884166116 https://pubmed.ncbi.nlm.nih.gov/PMC5520228
Volume	141
hasFullText	1
inHoldings	1
isFullTextHit
isPrint
link	http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1LT9tAEB7RHCouBQq04REtqAcOODibXTsWJ4QaBQQVqgrigGR5HxYpyEGJIxR-PTPrB00pUsXN0o4fuzvj-WZn9luAbzpCn2yl8ExEq1VJKj1CGZ7RnLhBhNBFgeyPYHApTq_l9QIcVnthCn6IesGNLMP9r8nAEzU5eCENHf7WbVTQDtFtU60WAaKfNXUUAZ2Sgdn3MBALKlYhnx_Ud877olcA83Wd5J_41Tmg_hLcVJ9e1J3ctae5auunv1gd39m3ZfhUAlN2VGjSCizY7DN8PC9T76tw5spuHofGMuW2PrBRyjTpzJgleXFuFm3DYvmIDS6umJoxSkzvM3caxXjGksy4Blr0XYPL_vdfxwOvPIrB08QP43HZlVqYxKLDwwguDLuREknXSI0-3nI_7QgjbaoiK5TGECpMQwxElEkwAEMQ1-uuQyMbZfYrsNC3VkTGV4j0hFS9XuprgQE6MRkGSukm7FWTEuuSp5yOy7iPC4ZlHuPoxG50mrBbiz4U5Bz_EtqqZjYu7XMSY5TqhxzhGTbv1M1oWZQuSTI7mqJMj1KyQYce8aVQhPotCMqCCIOTJoRzKlILEGv3fEs2vHXs3VJy4hzCbjoNePvD45PTY3ex8f-im7DICXcQZ6_cgkY-ntptRE25asEHLi5azkieAaSkEV0
linkProvider	Wiley-Blackwell
linkToHtml	http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1LT9tAEB6lILW9UCh9pA1lW3HooQ6Os2vHUi8VEBkIqEJJlUtleR9W0yIbBUcV_Hpm1g8aaKWKm6UdP3Z3xvPN7O43ADsqRJ9sBHd0SNmqJBUOoQxHK4-4QThX5QbZUz-a8KOpmLbgc30WpuSHaBJuZBn2f00GTgnp3VvW0NlP1UUN7fmPYJUqehNz_v5ZQx5FUKfiYHYdDMX8mlfI9XabW5e90T2IeX-n5J8I1rqg4TP4Xn98ufPkV3dRyK66vsPr-NDercNahU3Zl1KZNqBlsufw-KRafd-Ekd1583umDZP29APLU6ZIbeYsKcrSWXQSixU5i75-Y_KK0dr0J2YLUsyvWJJp20B53xcwGR6M9yKnqsbgKKKIcTzRF4rrxKDPwyAuCPqh5ElfC4Vu3nhu2uNamFSGhkuFUVSQBhiLSJ1gDIY4btB_CStZnpnXwALXGB5qVyLY40IOBqmrOMboRGboS6na8LGelVhVVOVUMeM8LkmWvRhHJ7aj04YPjehFyc_xN6FOPbVxZaKXMQaqbuAhQsPm900zGhetmCSZyRcoM6BVWb9Hj3hVakLzFsRlfojxSRuCJR1pBIi4e7klm_2wBN5CeEQ7hN20KvDvD48Pj_bsxZv_F92GJ9H4ZBSPDk-P38JTj2AIUfiKDqwU84XZQhBVyHfWVm4APHMUog
linkToPdf	http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwjV1LS8NAEB58QPEivq3PVTx4MJpud5MGT6KWtmrpQcVbyD6CFUmlVsR_78wmjRYVvBVmkjQzu5lvdna_ATjQEcZkK4VnIlqtSlLpEcrwjObEDSKEzjfIdoPWneg8yIcpOB2fhcn5IcoFN5oZ7ntNE_zFpCdfpKH9J32MA7QWTMMsFftoPxcXvbKEgEinoGD2PczEgjGtkM9Pyksng9EPhPlzo-R3AOsiUHMB5gvoyM5yXy_ClM2WoHJTFMeX4dptjHnvG8uUO5zABinT5NUhS0Z5Zys6KMVGA9bq3TP1wah0fMRcv4jhB0sy4wS0LLsCd83L2_OWVzRL8DQxuHhc1qUWJrEYkjDHCsN6pERSN1JjFLbcT2vCSJuqyAqlMckJ0xBTBWUSTJEQZjXqqzCTDTK7Diz0rRWR8RViMSFVo5H6WmAKTVyDgVK6Codjq8W6YBKnhhbPcc6BzGM0cOwMXIX9UvUlp8_4TWlrbPq4mEGvMeaRfsgRQKF4rxTj2KeCRpLZwRvqNKhoGtToFmu5p8qnIGwKIkwfqhBO-LBUIF7tSUnWf3T82lJyYgXC13Te_vuPx-3Oufux8X_VXaj0Lprxdbt7tQlznEACEezKLZgZDd_sNkKckdpxQ_kTwE7zGg
openUrl	ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Worldwide+burden+of+cancer+attributable+to+HPV+by+site%2C+country+and+HPV+type&rft.jtitle=International+journal+of+cancer&rft.au=de+Martel%2C+Catherine&rft.au=Plummer%2C+Martyn&rft.au=Vignat%2C+Jerome&rft.au=Franceschi%2C+Silvia&rft.date=2017-08-15&rft.issn=0020-7136&rft.eissn=1097-0215&rft.volume=141&rft.issue=4&rft.spage=664&rft.epage=670&rft_id=info:doi/10.1002%2Fijc.30716&rft.externalDBID=n%2Fa&rft.externalDocID=10_1002_ijc_30716
thumbnail_l	http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0020-7136&client=summon
thumbnail_m	http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0020-7136&client=summon
thumbnail_s	http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0020-7136&client=summon